Morphological and electrophysiological differences between the Caucasian and South Asian Atrium by O'Neill, James
Morphological and electrophysiological 
differences between the Caucasian and 
South Asian Atrium 
James O’Neill 
Submitted in accordance with the requirements for the degree of  
Doctor of Medicine (MD)  
The University of Leeds  
Faculty of Medicine and Health  
Leeds Institute of Cardiovascular and Metabolic Medicine 
& 
West Yorkshire Arrhythmia Service 
Leeds Teaching Hospitals NHS Trust 
October 2019
-i- 
 
Intellectual property and publication 
statements 
The candidate confirms that the work submitted is his/her own, except where work 
which has formed part of jointly-authored publications has been included. The 
contribution of the candidate and the other authors to this work has been explicitly 
indicated below. The candidate confirms that appropriate credit has been given 
within the thesis where reference has been made to the work of others.   
 
This copy has been supplied on the understanding that it is copyright material and 
that no quotation from the thesis may be published without proper 
acknowledgement. 
 
This copy has been supplied on the understanding that it is copyright material and 
that no quotation from the thesis may be published without proper 
acknowledgement. 
 
 
© 2019 The University of Leeds and James O’Neill. 
 
  
-ii- 
 
Authorship 
Individual contributions include: 
Chapter 1 
Publication: O'Neill, J, Tayebjee, MH. Why are South Asians seemingly protected 
against the development of atrial fibrillation? A review of current evidence. Trends 
Cardiovasc Med. 2017; 27: 249‐ 257. 
Author contributions: JO’N: Conception, design, literature search, drafting and 
revision of manuscript; MHT: conception, design and revision of manuscript. 
Chapter 2 
Publication: O'Neill, J, Jegodzinski, L, Tayebjee, MH. Incidence of subclinical atrial 
fibrillation in a South Asian population. Pacing Clin Electrophysiol. 2018; 41: 1600‐ 
1605. 
Author contributions: JO’N: Conception, design, collection of data, data analysis 
and interpretation of data, drafting and revision of manuscript; LJ: collection of data; 
MHT: conception, design, interpretation of data and revision of manuscript. 
Chapter 3 
Publication: O'Neill, J, Swoboda, PP, Plein, S, Tayebjee, MH. Left atrial size and 
function in a South Asian population and their potential influence on the risk of atrial 
fibrillation. Clin Cardiol. 2018; 41: 1379-1385. 
Author contributions: JO’N: Conception, design, collection of data, data analysis 
and interpretation of data, drafting and revision of manuscript; PPS: analysis and 
interpretation of data and revision of manuscript; SP: analysis and interpretation of 
-iii- 
 
data and revision of manuscript; MHT: conception, design, interpretation of data and 
revision of manuscript. 
Chapter 4 
Publication: O'Neill, J, Tayebjee, MH. Electrophysiological properties of the South 
Asian heart. Heart Asia. 2018; 10: e011079. 
Author contributions: JO’N: Conception, design, collection of data, data analysis 
and interpretation of data, drafting and revision of manuscript; MHT: conception, 
design, interpretation of data and revision of manuscript. 
Chapter 5 
Publication: O'Neill, J, Bounford, K, Anstey, A, D’Silva, J, Clark, L, Plein, S, 
Tayebjee, MH. P wave indices, heart rate variability and anthropometry in a healthy 
South Asian population. PLoS One. 2019; 14(8): pe0220662. 
Author contributions: JO’N: Conception, design, patient recruitment, collection of 
data, data analysis and interpretation of data, drafting and revision of manuscript; 
KB: collection of data and data analysis; AA: collection of data and data analysis; 
JD’S: collection of data and data analysis; LC: patient recruitment and collection of 
data; SP: interpretation of data and revision of manuscript; MHT: conception, 
design, interpretation of data and revision of manuscript. 
 
  
-iv- 
 
Publications arising from this work 
Papers 
1. O'Neill, J, Tayebjee, MH. Why are South Asians seemingly protected 
against the development of atrial fibrillation? A review of current evidence. 
Trends Cardiovasc Med. 2017; 27: 249‐ 257. 
2. O'Neill, J, Jegodzinski, L, Tayebjee, MH. Incidence of subclinical atrial 
fibrillation in a South Asian population. Pacing Clin Electrophysiol. 2018; 41: 
1600‐ 1605. 
3. O'Neill, J, Swoboda, PP, Plein, S, Tayebjee, MH. Left atrial size and 
function in a South Asian population and their potential influence on the risk 
of atrial fibrillation. Clin Cardiol. 2018; 41: 1379-1385. 
4. O'Neill, J, Tayebjee, MH. Electrophysiological properties of the South Asian 
heart. Heart Asia. 2018; 10: e011079. 
5. O'Neill, J, Bounford, K, Anstey, A, D’Silva, J, Clark, L, Plein, S, Tayebjee, 
MH. P wave indices, heart rate variability and anthropometry in a healthy 
South Asian population. PLoS One. 2019; 14(8): pe0220662. 
Abstracts 
1. O'Neill, J, Jegodzinski, L, Tayebjee, MH. Incidence of subclinical atrial 
fibrillation in a South Asian population. Europace. 2018; 20:Suppl 4 iv37-
iv38.  
-v- 
 
2. O'Neill, J, Swoboda, PP, Plein, S, Tayebjee, MH. Left atrial size and 
function in a South Asian population and their potential influence on the risk 
of atrial fibrillation. Europace. 2018; 20:Suppl 4 iv37. 
3. O'Neill, J, Tayebjee, MH. Electrophysiological properties of the South Asian 
heart. Europace. 2018; 20:Suppl 4 iv37. 
4. O'Neill, J, Bounford, K, Anstey, A, D’Silva, J, Clark, L, Plein, S, Tayebjee, 
MH. P wave indices, ECG reference ranges and anthropometric 
measurements in a healthy South Asian population. European Journal of 
Arrhythmia & Electrophysiology. 2019;5(Suppl. 1). 
5. O'Neill, J, Bounford, K, Anstey, A, D’Silva, J, Clark, L, Plein, S, Tayebjee, 
MH. Heart rate variability and anthropometric measurements in a healthy 
South Asian population. European Journal of Arrhythmia & 
Electrophysiology. 2019;5(Suppl. 1). 
  
-vi- 
 
Acknowledgements 
This body of work would not have been possible without the support of others. 
Firstly, I would like to thank Dr Muzahir Tayebjee for giving me this opportunity and 
for his guidance, support and encouragement over the last few years. His 
enthusiasm, work ethic and dedication to research whilst maintaining his vast 
clinical responsibilities have been a great example to me and are qualities I hope to 
aspire to throughout my career. 
I would like to thank Professor Sven Plein, Professor Arun Holden and Dr Peter 
Swoboda for their invaluable advice and for ensuring my needs as a researcher and 
student were always met. 
Special thanks also goes to Julie Corrigan and Claire Forrest within the Clinical 
Research Facility for providing me with a base to work from and for their frequent 
cups of tea; and to Lisa Clark, Katrina Gilbert, Alice Anstey and Jesvita D’Silva for 
their assistance with recruitment and help with the cardiac investigations. 
I am forever grateful to the volunteers who agreed to participate in this research 
project.  Every participant took time out of their busy lives to help me and I would 
like to thank each and every one of them for enabling me to achieve my aims.  
To my parents, thank you for always being there for me. Everything I have ever 
achieved is a consequence of your love and guidance.  
Finally, I would like to thank my wife Louise for her encouragement and patience 
over the last three years. Your love and unwavering support have enabled me to 
accomplish things I didn’t think were possible. And to our children, Finlay and Alice, 
thank you for giving me the inspiration to succeed. I will be forever indebted to you 
all.  
-vii- 
 
Abstract 
Introduction:   South Asians (SAs) have a low prevalence of atrial fibrillation (AF) 
compared with Caucasians despite a higher prevalence of hypertension, diabetes 
mellitus and coronary artery disease. The aim of this thesis was to determine 
whether this was related to an under-detection of the arrhythmia and if not, whether 
differences in left atrial (LA) size, electrophysiological properties or autonomic 
function in SAs might help to explain this disparity. 
Methods:   Retrospective and prospective cohort studies were performed  on SA 
and Caucasian participants using data from implantable cardiac devices, cardiac 
magnetic resonance imaging scans, invasive electrophysiology studies and a range 
of non-invasive cardiac investigations. 
Results:   The cumulative incidence of subclinical AF was significantly lower in SAs 
compared with Caucasians (log rank p=0.002) with an annual event rate of 6.9% 
versus 13.9%. In comparison with Caucasians, SAs were of a smaller height with 
lower lean body mass and higher waist:hip ratio;  had lower minimum (27.7±11.1 ml 
vs 34.9±12.3 ml, p=0.002) and maximum LA volumes (64.7±21.1 ml vs 80.9±22.5 
ml, p<0.001) even after matching for body surface area; lower P wave dispersion 
(males 28.0(12)ms vs 25.0(12)ms, p=0.039; females 24.0(12)ms vs 22.0(12)ms, 
p=0.004) and P wave terminal force in lead V1 (males 0.031(0.04)mm•s vs 
0.021(0.03) mm•s, p=0.023; females 0.036(0.04)mm•s vs 0.034(0.04)mm•s, 
p=0.030), electrophysiological variations related to the inhomogeneity of LA 
conduction and LA size respectively; increased heart rate (82.5(18)bpm vs 
78.0(18)bpm, p=0.024), lower atrioventricular (280(50)ms vs 300(60)ms, p=0.001) 
and ventriculoatrial (300(60)ms vs 320(93)ms, p=0.013) effective refractory periods 
-viii- 
 
and lower heart rate variability (in SA males), suggestive of sympathetic 
predominance. 
Conclusions:   SAs have reduced LA size and evidence of increased sympathetic 
tone and reduced inhomogeneity in LA conduction. The morphological, 
electrophysiological and autonomic differences identified in SAs may help to explain 
why this ethnic group has a lower prevalence of AF. 
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Chapter 1. Introduction 
1.1 Atrial fibrillation 
Atrial fibrillation (AF) is a supraventricular arrhythmia characterised by irregular, 
rapid and uncoordinated atrial depolarisations resulting in atrial mechanical 
dysfunction1. It is the commonest sustained cardiac arrhythmia2 with an estimated 
prevalence of 3% in adults aged 20 years or older3. This figure is expected to rise 
further, potentially more than doubling over the next 50 years4. It is associated with 
a five-fold risk of stroke, a three-fold incidence of heart failure5 and a 1.5- to 1.9-fold 
increase in mortality6 as well as having a significant impact on patients’ quality of 
life. As a consequence, AF has become a major public health burden with current 
estimates suggesting that it accounts for around 1% of the total National Health 
Service budget in the United Kingdom (UK)7 and between $6-26 billion of annual 
healthcare expenditure in the United States of America (USA)8. 
Observational studies have repeatedly shown that the South Asian population has a 
low prevalence of AF in comparison to Caucasians9-13. This finding is particularly 
surprising since South Asians have a high burden of established cardiovascular risk 
factors for the arrhythmia. The underlying mechanisms that seemingly protect South 
Asians against the development of AF remain uncertain.  
In the following sections, an overview of the pathophysiology, aetiology and 
epidemiology of AF is provided. A comprehensive review of the literature relating to 
AF and South Asians is subsequently performed and areas of further investigation 
are proposed. 
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1.2 Pathophysiology 
The exact mechanisms responsible for the initiation and maintenance of AF, one of 
the most complex heart rhythm disorders, are yet to be fully determined although 
multiple theories have been proposed (figure 1). At the beginning of the 20th 
Century, AF was believed to be related to either circus movement re-entry14, in 
which an impulse propagated around an anatomical or functional obstacle leading to 
re-excitation of the heart, or ectopic focus re-entry15, involving rapidly discharging 
ectopic atrial foci. 
By the mid-20th Century, the multiple wavelet hypothesis had been proposed16. This 
theory suggested that AF was perpetuated by continuous conduction of several 
independent wavelets randomly propagating through the atria in a seemingly 
chaotic manner. In order for fibrillatory conduction to persist, the theory stated that a 
critical number of re-entrant wavefronts had to be present within a vulnerable atrial 
substrate. This theory was supported by experimental evidence in a canine model of 
AF induced by infusion of acetylcysteine and rapid pacing17. It was shown that just 
four to six independent wavelets propagating simultaneously were required to 
sustain arrhythmia. These findings were reproduced in subsequent studies18. The 
development of the surgical maze procedure19, in which the atrium is 
compartmentalised to prevent the propagation of multiple wavelet re-entrant circuits, 
provided further support for the multiple wavelet hypothesis by preventing AF. 
More recently, it has become clear that the mechanisms underlying paroxysmal AF 
differ from persistent AF. It is now known that focal discharges from pulmonary 
veins are the main trigger for the initiation of paroxysmal AF20. This finding has led 
to pulmonary vein isolation becoming a first-line therapy in the treatment of 
paroxysmal AF. Although this technique is applied in patients with persistent AF, 
long-term success rates are significantly lower, highlighting the mechanistic 
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differences that exist21. It is currently believed that focal ectopic discharges initiate 
AF but multiple wavelet re-entry maintains the arrhythmia. Over time, due to 
abnormal atrial remodelling, episodes of AF can become increasingly frequent and 
prolonged until they no longer terminate spontaneously and the condition evolves 
from a paroxysmal to persistent form. 
 
Figure 1. Classical mechanisms for the initiation of atrial fibrillation22. 
A. Ectopic focus;    B. Single circuit re-entry;    C. Multiple wavelet re-entry 
1.2.1 Initiation of atrial fibrillation 
Whilst the myocardial sleeves that surround the pulmonary veins are thought to be 
the primary source of ectopy triggering AF20, other sites have been implicated 
including the superior vena cava, left atrial posterior free wall, crista terminalis, 
coronary sinus ostium, ligament of Marshall and interatrial septum23. The 
electrophysiological mechanism underlying the initiation of AF through ectopic 
triggers is not yet fully understood but it has been associated with enhanced 
automaticity24 and triggered activity25, 26 (figure 2). 
Automaticity refers to the ability of cardiac cells to generate spontaneous action 
potentials. It is an intrinsic property of all myocardial cells but due to the natural 
hierarchy of pacemaker function, in normal cardiac conduction, spontaneous activity 
is usually restricted to pacemaker cells within the sino-atrial node. Normal 
A. B. C. 
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automaticity involves spontaneous diastolic depolarisation of the membrane 
potential, predominantly by the pacemaker current (If)27, until a threshold potential is 
reached and an action potential is generated.  
 
Figure 2. Electrophysiological mechanisms underlying the initiation of atrial 
fibrillation in non-pacemaker atrial cells. 
A. Normal action potential;   B. Enhanced automaticity; 
C. Early afterdepolarisations;   D. Delayed afterdepolarisations 
Enhanced automaticity occurs if non-pacemaker atrial myocytes depolarise more 
rapidly (phase 4 of the action potential) than the sino-atrial node. This results in the 
formation of an atrial ectopic beat which overrides the sino-atrial node and can 
trigger AF28. The basic mechanism underlying enhanced automaticity relates to 
changes in the balance of ionic channels. Following repolarisation, the resting 
potential of atrial myocytes is maintained by high resting potassium permeability 
A. B. 
C. D. 
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through the inward rectifier potassium current (IK1)29. Although normal, non-
pacemaker atrial cells also manifest If current, this is usually overwhelmed by the 
much larger IK1 and these cells do not manifest automaticity. However, enhanced 
automaticity can occur when there is a change in this balance, due to decreased IK1 
and/or increased If 29. 
Triggered activity results from the premature activation of myocytes by 
afterdepolarisations, membrane potential oscillations which follow the upstroke of an 
action potential. Early afterdepolarisations occur during the repolarisation phase of 
the cardiac action potential (phase 3). They are primarily a result of prolonged atrial 
cell action potential duration (APD) which allows L-type calcium currents (ICaL) time 
to recover from inactivation. This leads to the inward movement of calcium ions, 
abnormally depolarising the membrane potential and, if the threshold potential is 
reached triggering ectopy29.  
Delayed afterdepolarisations occur following complete repolarisation (phase 4) of 
the action potential but prior to the next normal action potential. They are a 
consequence of intracellular calcium overload. This induces the abnormal release of 
calcium from the sarcoplasmic reticulum and leads to the activation of the transient 
inward current (ITI) which regulates membrane depolarisation30. If the inward current 
produced by the delayed afterdepolarisation becomes large enough to reach 
threshold potential, an abnormal depolarisation occurs, triggering ectopy or 
tachycardia28. 
1.2.2 Maintenance of atrial fibrillation 
Electrical and structural remodelling within atrial tissue plays a key role in the 
maintenance of AF and this is further enhanced through alterations in autonomic 
tone. AF is a self-perpetuating arrhythmia whereby an increase in its burden creates 
-6- 
 
suitable conditions for remodelling and this in turn facilitates more AF, a concept 
that has previously been termed ‘AF begets AF’ 31. 
Electrical remodelling alters ion channel expression and function and can occur 
within minutes of the onset of AF. Calcium enters atrial myocytes with every action 
potential and so during rapid atrial rates, like those seen in AF, excessive calcium 
loading can occur. To counteract this, autoprotective mechanisms are activated, 
leading to a downregulation in ICaL, an increase in IK1 and a reduction in transient 
outward potassium currents (Ito) within atrial myocytes31-35. Although the overall 
effect of these changes is a reduction in calcium loading, there is also a shortening 
of the atrial cell APD. By reducing APD, atrial re-entry circuits are able to stabilise, 
increasing AF vulnerability and sustainability36, 37. 
Structural remodelling is a more gradual process characterised by atrial 
enlargement and tissue fibrosis. These changes are driven by sustained rapid atrial 
rates as well as volume and pressure changes within the atrium which occur as a 
result of left ventricular dysfunction or valvular disease. Atrial size has consistently 
been shown to be associated with AF. The Framingham Heart Study38 showed that 
a 5mm increase in left atrial diameter increased the risk of AF by 39% whilst the 
Cardiovascular Health Study39 showed that a left atrial diameter of more than 5cm 
was related to a 4-fold increase in the risk of AF. Tsang et al found that LA volume 
was an independent predictor of AF, that a 30% larger LA volume equated to a 43% 
greater risk of AF40 and that a 5mm increase in LA dimension increased the risk of 
AF by 48%41. Mathematical models indicate that this may be due to increased local 
intra-atrial conduction block, creating smaller and more numerous re-entrant circuits 
which in turn, favour the persistence of AF42.  
Atrial fibrosis disrupts the propagation of electrical impulses through the atria, 
leading to inhomogeneity in atrial conduction. This can promote re-entry and ectopic 
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activity, thereby creating substrate for AF. Fibrosis occurs both as a result of atrial 
enlargement and as a consequence of rapid atrial rates through the upregulation 
and expression of pro-fibrotic factors such as transforming growth factor beta-1 and 
angiotensin-II and through the stimulation of oxidative stress and inflammation43. 
This inflammation can then lead to the over-expression of matrix 
metalloproteinases, substances involved in extracellular matrix homeostasis, which 
in turn increase collagen concentration within the myocardium and stimulate 
connective tissue synthesis43. 
The autonomic nervous system heavily influences heart rate, atrioventricular nodal 
conduction velocity and cardiac contractility through a complex interaction between 
sympathetic and parasympathetic innervation. Paroxysmal AF is commonly 
preceded by an increase in parasympathetic activity, particularly in those without 
structural heart disease44. Vagal stimulation causes heterogeneous shortening of 
atrial APD and atrial ERP through the activation of acetylcholine-dependent 
potassium channels (IKACh) and suppression of ICaL, stabilising re-entrant circuits and 
increasing AF vulnerability45-47. Increased sympathetic activity has also been linked 
to the development of AF through its effects on atrial refractoriness and increasing 
atrial automaticity although this appears to be primarily in patients with underlying 
structural heart disease48-51. 
1.3 Aetiology 
Atrial fibrillation occurring in the apparent absence of structural or valvular heart 
disease has previously been termed idiopathic or lone AF52. They are terms which 
have become outdated and increasingly avoided as the understanding of the 
aetiology of AF improves53. There is evidence to suggest that many cases of “lone 
AF” are in fact related to either underlying inflammatory changes within the atria54 or 
genetic mutations in transcription factors specifically involved in atrial 
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development55, 56. The vast majority of AF cases occur as a consequence of atrial 
remodelling caused by structural heart disease or a known cardiovascular risk 
factor. 
1.3.1 Hypertension 
Hypertension is the most prevalent, independent and potentially modifiable risk 
factor for AF57. Two mechanisms have been proposed to explain this. Firstly, 
uncontrolled hypertension triggers the development of left ventricular hypertrophy 
(LVH). Abnormal thickening of the myocardium increases ventricular stiffness, 
leading to elevated left ventricular diastolic filling pressures and, in turn, increased 
left atrial pressure, atrial stretch and atrial fibrosis57. Secondly, hypertension causes 
alterations in atrial electrophysiology. Studies involving animal and human models 
have found that a chronic elevation in blood pressure prolongs atrial conduction 
velocity and reduces atrial ERP58-60, factors which promote re-entry and can trigger 
AF. 
Hypertension is present in around half of all patients with AF61 and, after adjustment 
for other risk factors, it has been shown to be associated with a 1.5-fold and 1.4-fold 
risk of AF for men and women respectively62. 
1.3.2 Diabetes mellitus 
Diabetes mellitus was first shown to be an independent risk factor for in AF in the 
Framingham study with an odds ratio of 1.4 in males and 1.6 in females63. More 
recently, a large registry study with 845,748 patients found that AF occurred in 
14.9% of diabetic patients versus 10.3% of control patients (p<0.001) and showed 
that it was associated 2.13-fold risk of AF64. 
Diabetes mellitus has been shown to increase left ventricular mass and wall 
thickness, reduce left ventricular function and increase arterial stiffness65. The 
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cumulative effects of these structural changes are an increase in left atrial pressure, 
left atrial enlargement and atrial fibrosis, all of which favour the development of AF. 
1.3.3 Coronary artery disease 
Acute myocardial infarction (MI) is an established risk factor for AF with one 
systematic review reporting an AF incidence rate of between 6 and 21% in patients 
suffering acute MI66. Additionally, patients who have a transient episode of AF 
during acute MI have a recurrence rate of around 20% at one year67. Atrial 
ischaemia and infarction are the dominant pathophysiological factors in the 
development of AF but left ventricular infarction and the resultant ventricular 
dysfunction, raised left atrial pressures and atrial stretch, also play a role. 
In patients with established coronary artery disease, the long-term risk of AF is also 
higher. One study which followed-up air force pilots over a 44-year period found that 
those with a prior history of MI had a 3.62-fold risk of AF whilst those with a 
diagnosis of angina had a 2.84-fold risk of the arrhythmia61. In a large cross-
sectional study of 15,406 individuals living in Scotland, myocardial ischaemia was 
associated with 4.5-fold risk of incident AF68. Once again, the mechanism 
underlying this is likely to be related to chronic atrial ischaemia69. 
1.3.4 Congestive heart failure 
A close and complex relationship exists between AF and congestive heart failure. 
Indeed, at times, it can be a diagnostic challenge to determine which is cause and 
which is effect. More than half of all patients with a new diagnosis of heart failure 
have co-existent AF and over a third of patients with new-onset AF are found to 
have congestive heart failure70. In patients with heart failure, the prevalence of AF is 
closely correlated with the severity of the disease. Patients with New York Heart 
Association (NYHA) functional class I symptoms have an AF prevalence of less 
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than 5%, those with NYHA class II or III symptoms have an AF prevalence of 
around 25% whilst patients with NYHA class IV symptoms have an AF prevalence 
of almost 50%71. 
Though the pathophysiological mechanisms are not fully understood, the two 
conditions certainly share a number of common risk factors such as hypertension, 
diabetes mellitus, coronary artery disease and age and it is likely that each condition 
predisposes the heart to the development of the other. For instance, heart failure 
increases left ventricular end-diastolic pressure which in turn increases left atrial 
pressure. This leads to atrial enlargement and fibrosis, thereby creating an 
environment capable of sustaining AF71. Conversely, AF causes atrioventricular 
dyssynchrony and a loss of atrial contraction which can lead to impaired diastolic 
filling, reduced stroke volume and around a 20% reduction in cardiac output72. 
Additionally, an uncontrolled rapid ventricular rate which can accompany AF can 
lead to a phenomenon known as tachycardia-induced cardiomyopathy. This occurs 
when rapid ventricular rates result in elevated left ventricular filling pressures, 
decreased contractility and reduced cardiac output, eventually leading to left 
ventricular dilatation and heart failure73, 74. The mechanisms underlying this are not 
fully defined but are believed to be related to abnormal calcium handling, 
abnormalities in energy metabolism and subclinical ischaemia75, 76. 
1.3.5 Valvular heart disease 
Valvular heart disease has been associated with a 1.8-fold and 3.4-fold increased 
risk of AF in males and females respectively63. Although any form of valvular heart 
disease can be related to AF, stenotic left-sided valvular lesions, and particularly 
those related to rheumatic fever, have the highest prevalence rates77. In a similar 
way to heart failure, the prevalence of AF correlates with the severity of the valvular 
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obstruction. AF prevalence is 9.1% in patients with mild or moderate aortic 
stenosis78, rising to 33.7% in those with severe aortic stenosis79.  
Valvular heart disease promotes AF via structural remodelling. Increased atrial 
pressure or volume loading as a consequence of a stenotic or regurgitant valve 
causes atrial enlargement and interstitial fibrosis, providing substrate for the 
development of AF80. 
1.3.6 Obesity 
Obesity is an independent risk factor for AF81 and it is currently the second highest 
population-attributable risk for the arrhythmia behind hypertension82. In the 
Framingham study, for every one unit increase in body mass index (BMI), the risk of 
AF increased by 4%81. Dynamic changes in weight can also influence AF risk. The 
Women’s Health Study showed that moving from one weight category to the next 
(normal weight [BMI <25kg/m2], overweight [BMI 25-29.99kg/m2], obese [≥30kg/m2]) 
increased or decreased the risk of AF in line with the direction of movement83. 
Furthermore, the risk of progression from paroxysmal to persistent AF has been 
shown to increase as the severity of obesity increases (HR 1.54 for BMI 30-34kg/m2 
and 1.87 for BMI ≥35kg/m2)84. 
Obesity promotes left ventricular diastolic dysfunction and end-diastolic pressure as 
a consequence of myocardial fatty infiltration85. These alterations in cardiac function 
in turn, increase left ventricular mass, left atrial pressure and left atrial volume 
resulting in AF susceptibility86. Additionally, obesity causes inflammatory infiltrates 
and atrial interstitial fibrosis with the effect of slowing atrial conduction and 
increasing conduction heterogeneity86. 
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1.3.7 Obstructive sleep apnoea 
Obstructive sleep apnoea (OSA) is closely related to obesity with more than 40% of 
obese individuals having the condition87. Despite this, the relationship between OSA 
and AF has been shown to be independent of obesity88. One study has found that 
the risk of AF in patients with severe OSA is up to four times higher than those 
without OSA89. The presence of OSA also increases the risk of AF recurrence 
following catheter ablation by 25%90 and cardioversion by 29%91. 
It remains a matter of debate as to whether OSA is a direct cause of AF or whether 
it simply reflects a shared risk factor profile, particularly in relation to obesity. 
However, an animal model has shown that the strongly negative intrathoracic 
pressures which occur during OSA increase venous return and enhance left atrial 
volume loading, leading to acute left atrial stretch and increased AF inducibility92. 
Interestingly, in this study, AF inducibility was not enhanced in obese or lean rats in 
the absence of OSA92. 
1.3.8 Thyroid dysfunction 
Hyperthyroidism is an established risk factor for AF and those with the condition 
have a 3- to 6-fold increased incidence of AF compared with those with normal 
thyroid function77. Several mechanisms have been proposed to explain this. 
Hyperthyroidism causes autonomic imbalance with an increase in sympathetic 
tone93. This increases heart rate and cardiac inotropy which can cause subclinical 
ischaemia and over time lead to diastolic dysfunction, increased left ventricular 
mass and elevated left atrial pressure94-96.  Additionally, higher sympathetic tone can 
enhance AF vulnerability by reducing atrial refractoriness and increasing 
automaticity and triggered activity51, 97-99. 
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1.3.9 Anthropometry 
Lean body mass, the difference between total body weight and body fat weight, has 
recently been shown to be the predominant anthropometric risk factor associated 
with the occurrence of AF100. A population-based study of 55,273 individuals found 
that lean body mass was associated with 37% increased risk of AF whilst other 
anthropometric measures such as fat mass, BMI and waist-to-hip ratio did not 
remain significant after adjustment for lean body mass. Lean body mass, which 
includes organ cell mass and non-fatty tissues such as muscles, bones and 
connective tissue, is responsible for almost all metabolic activity within the body and 
governs total oxygen demand; this in turn determines the required cardiac output 
and stroke volume101. Increased stroke volume as a result of lean body mass can 
lead to the development of LVH101 and elevated left ventricular end-diastolic 
pressure which in turn, increases left atrial pressure and volume load, causing left 
atrial enlargement and wall stress101, conditions which provide favourable substrate 
for AF development. 
Height is closely related to left atrial volume102 and so it is perhaps not surprising 
that height has been shown to be independently associated with the development of 
AF in multiple studies103, 104. Indeed the risk of AF increases by 35-65% for every 
10cm difference in height104. However, one study has also found that the impact of 
height on the risk of AF is independent of atrial size103. The reason for this is 
uncertain but it has been speculated that the height-mediated increased AF risk 
may relate the genetic variations; recent genome-wide association studies have 
identified two genes, PITX2 and SFHX3, which are associated with growth 
pathways and an increased risk of AF105, 106.  
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1.3.10 Alcohol 
Excessive alcohol consumption (≥36g/day or approximately >3 drinks/day) is an 
established cause of AF with an adjusted hazard ratio ranging between 1.34 and 
1.46107, 108. There is emerging evidence that even moderate levels of alcohol 
consumption (1-3 drinks/day) can increase the risk of AF by up to 14%109. 
A number of mechanisms have been postulated to explain the effects of alcohol on 
AF risk. Alcohol causes autonomic imbalance with an initial increase in sympathetic 
activity, followed by a compensatory rise in vagal tone. Sympathetic activity 
stimulates automaticity and triggered activity whilst vagal stimulation reduces atrial 
ERP and APD non-uniformly, facilitating re-entry51, 110, 111. Alcohol can also affect 
traditional risk factors for AF. For instance, chronic alcohol abuse is associated with 
hypertension112, obesity113, OSA114 and cardiomyopathy115. Overall, it is likely that 
alcohol increases the risk of AF through a combination of direct effects on the atrial 
substrate and by contributing to other AF-related risk factors. 
1.3.11 Physical activity 
The association between exercise and the risk of AF follows a J-shaped curve with 
increasing physical activity modestly reducing the risk of AF but extreme exercise, 
such as that performed by endurance athletes, increasing the risk of AF 
significantly. The Cardiovascular Health Study found that those with the highest self-
reported physical activity had a 46% reduction in AF risk116 and these findings were 
reinforced by large population-based studies of Swedish men and women which 
showed that daily exercise lowered the risk of AF by 13% in men and 19% in 
women117, 118. In contrast, a meta-analysis examining the arrhythmia in athletes 
found that intense physical exercise was associated with a five-fold increase in the 
risk of AF119. 
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Exercise generally has a positive influence on risk factors such as hypertension, 
glycaemic control and body weight and has been shown to slow the age-related 
decline in arterial elasticity and associated cardiovascular disease. However, at high 
levels, exercise can lead to morphological changes such as left atrial enlargement 
and LVH, the development of atrial fibrosis and increased vagal tone, all of which 
favour AF120. 
1.3.12 Genetics 
In recent years, studies have suggested a probable link between genetics 
and the development of AF. Those examining familial AF have found that mutations 
within genes encoding potassium and sodium ion channels play an important role in 
the development of the condition (Table 1)121. The first gene that was linked to 
familial AF was KCNQ1 which is required for the expression of the slowly activating 
delayed rectifier potassium channel (IKs)122. A gain-of-function mutation in this gene 
was shown to increase IKs and reduce atrial APD and ERP, creating a substrate for 
AF122, 123. Since then gain-of-function mutations in KCNH2, KCND3 and KCNJ2 
which are responsible for the expression of the rapidly activating delayed rectifier 
potassium channel (IKr), Ito, and IK1 respectively, have been linked to the 
development of AF124-126. Mutations in genes responsible for voltage-gated sodium 
channels have also been seen. A combination of gain-of function and loss-of-
function mutations in the SCN5A and SCN10A genes (responsible for the 
expression of Nav1.5 and Nav 1.8 sodium channels respectively) have been shown 
to prolong atrial APD and promote early after-depolarisations, increasing AF 
vulnerability127-129. 
Mutations which have been linked to AF can also occur in genes unrelated 
to ion channels. GJA5 encodes connexin-40, a gap junction protein which is 
responsible for the rapid conduction of action potentials between cardiomyocytes. 
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Mutations of this GJA5 may predispose to AF by prolonging atrial APD and 
promoting re-entry circuits130. Another gene, NPPA, encodes a precursor for atrial 
natriuretic peptide (ANP). Mutations within this gene produce a variant of ANP 
which is resistant to degradation131. Increased ANP levels subsequently shorten 
atrial ERP and APD132 and over time may promote atrial remodelling and 
dilatation133, changes which provide substrate for the development of AF. 
 
Table 1. Potassium and sodium channel mutations linked to atrial fibrillation 
Potassium channel mutations 
Gene Locus Product Ion channel Type Mechanism 
KCNQ1 11P15.5-P15.4 
α-subunit of voltage-
gated potassium 
channel Kv7.1 
IKs Gain-of-function ↓ atrial ERP and APD 
 KCNH2 7q36.1 
α-subunit of voltage-
gated potassium 
channel Kv11.1 
IKr Gain-of-function ↓ atrial APD 
KCND3 1p13.2 
α-subunit of voltage-
gated potassium 
channel Kv4.3 
Ito Gain-of-function Unknown 
KCNJ2 17q24.3 
α-subunit of voltage-
gated potassium 
channel Kir2.1 
IK1 Gain-of-function ↓ atrial APD 
Sodium channel mutations 
Gene Locus Product Function Type Mechanism 
SCN5A 3p22.2 α-subunit of Nav1.5 INa Gain-of-function Loss-of-function 
↑ atrial APD 
↑ EADs 
SCN10A 3p22.2 α-subunit of Nav1.8 INa-L Gain-of-function Loss-of-function 
↑ atrial APD 
↑ EADs 
Abbreviations: ERP, effective refractory period; APD, action potential duration; EADs, Early 
afterdepolarisations 
 
A genome-wide association study (GWAS) is a novel approach whereby 
complete sets of DNA are examined in individuals with the same condition in an 
attempt to find genetic similarities. Over the last decade, these studies have 
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identified 27 genetic loci containing 29 single-nucleotide polymorphisms (SNPs) 
which have a modest association with AF121, 123. 
The first of these studies was performed on an Icelandic population in 2006 
and the SNP which was associated most strongly with the development of AF was 
rs2200733T at the chromosome 4q25 locus105. Within the same study, this same 
SNP was closely related to cases of AF within a Han-Chinese population from Hong 
Kong. Studies have since shown a similar relationship in African-Americans134, 
Japanese135 and other European cohorts136.  
 
1.4 Epidemiology 
The burden of AF varies with age, gender, geographical region and ethnicity but 
overall estimates suggest that it currently affects around 33.5 million individuals 
worldwide12.  
1.4.1 Age 
The risk of developing AF is associated with increasing age. It is rare in children or 
healthy, young adults in the absence of structural heart disease. The prevalence of 
AF ranges from 0.1% in individuals below 55 years, 3.8% in individuals aged more 
than 60 and 10% in individuals above the age of 804. A literature review which is 
summarised in table 2 highlights the effect of age on the prevalence of AF.  
In the coming years, as a consequence of population ageing, the prevalence of AF 
is expected to increase further. In Europe, AF is projected to increase from a current 
estimated prevalence of 8.8 million to around 18 million by 2060137 whilst in the 
USA, the prevalence of AF is expected to more than double from 5.2 million to 
around 12.1 million by 2030138. 
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The incidence of AF also increases with advancing age. An observational study 
which followed up 3,983 healthy subjects over a 40 year period demonstrated an AF 
incidence of 0.5 per 1,000 person-years before the age of 50, rising to 9.7 per 1,000 
person-years after the age of 7061. Estimates for the lifetime risk of AF are 
predominantly derived from developed countries in the Western world139, 140. Since 
the incidence of AF increases rapidly with each decade, the lifetime risk does not 
change significantly with increasing index age. Hence, individuals aged 40 have a 
lifetime risk of AF of around 25% whilst those aged 80 have a risk of around 22%. 
Age increases the risk of AF through a combination of structural, 
electrophysiological and molecular changes as a result of aging itself and as a 
consequence of age-related comorbidities such as hypertension, diabetes mellitus, 
coronary artery disease and heart failure141. Left atrial size, a structural change 
which favours the perpetuation of AF, and atrial fibrosis both increase with age142, 
143. These structural changes lead to inhomogeneity in atrial conduction, promoting 
re-entry and increasing AF vulnerability. Aging is associated with atrial APD 
prolongation and with an increase in spontaneous diastolic calcium release from the 
sarcoplasmic reticulum, changes that favour the development of 
afterdepolarisations and ectopic activity141, 144. There is also evidence indicating that 
atrial conduction disturbances may relate to alterations in membrane protein 
expression. Animal studies have found an association between increasing age and 
a downregulation of connexin-43145. A reduction in connexin-43 has, in turn, been 
shown to promote re-entry and AF in aging human hearts146. 
1.4.2 Gender 
The prevalence of AF is significantly higher in men, regardless of age. Table 2 
summarises previous epidemiological studies examining the effects of gender on 
the prevalence of AF. In a large observational study of North American adults aged 
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20 years and above, the prevalence of AF was 1.1% in men and 0.8% in women 
(p<0.001)4 whilst in a study of European adults aged 20 years and above, the 
prevalence of AF was even higher, affecting 3.3% of men and 2.5% of women 
(p<0.001)147. 
The incidence of AF is also higher in men at all age groups12, 139, 140. After 
adjustment for age and other risk factors, AF in men has been shown to develop at 
a rate 1.5 times that of women63. In 2010, the worldwide estimated incidence rate of 
AF was 77.5 per 100,000 person-years in men and 59.5 per 100,000 person-years 
in women. Applying these estimated incidence rates to a world population would 
therefore suggest that the annual number of new AF cases is 2.7 million for men 
and 2.0 million for women. 
 Table 2. Literature review of AF prevalence and incidence based on gender and age  
Author (year) Study location Study design Participants 
Age range 
(years) 
Prevalence Incidence 
Prevalence (age 
range) Men (%) Women (%) 
Total 
(%) 
Men (/1000 
person-
years) 
Women (/1000 
person-years) 
Go et al.4 
(2001) 
USA  1,890,000 ≥20 1.1 0.8 0.95 - - <55 years: 0.1% >80 years: 9.0% 
Kannel et al.62 
(1998) 
USA  4,731 65-84 9.1 4.7 6.9 - - <59 years: 0.5% >80 years: 9.0% 
Furberg et al.148 
(1994) 
USA  5,201 ≥65 6.2 4.8 5.5 - - - 
Wolf et al.149 
(1991) 
USA  5,070 >50 - - 4.0 - - - 
Murphy et al.150 
(2007) 
UK Retrospective cohort study 362,155 ≥18 0.9 0.8 0.9 0.9 0.8 
<65 years: 0.3% 
>75 years: 7.5% 
DeWilde et al.151 
(2006) 
UK Retrospective cohort study 1,000,000 All ages 1.3 1.1 - - - - 
Majeed et al.152 
(2001) 
UK Retrospective cohort study 1,400,000 ≥20 1.2 1.3 1.2 - - 
<65 years: 0.3% 
>85 years: 10.8% 
Stewart et al.68 
(2001) 
UK  15,406 45-64 0.8 0.5 0.65 0.9 0.25 - 
Sudlow et al.153 
(1998) 
UK Prospective cohort study 4,843 ≥65 6.7 4.0 4.7 - - - 
Friberg et al.147 
(2013) 
Sweden Retrospective cohort study 7,200,000 20 3.3 2.5 2.9 - - 
<60 years: 0.6% 
>80 years:11.2% 
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Table 2. Literature review of AF prevalence and incidence based on gender and age (continued) 
Author (year) Study location 
Study 
design Participants 
Age range 
(years) 
Prevalence Incidence 
Prevalence (age 
range) Men (%) Women (%) 
Total 
(%) 
Men (/1000 
person-
years) 
Women 
(/1000 
person-years) 
Wilke et al.154 
(2013) Germany 
Retrospective 
cohort study 8,298,000 0-90 2.4 1.9 2.1 4.4 3.9 
<60 years: 0.3% 
>80 years: 13.8% 
Guize et al.155 
(2007) France 
Retrospective 
cohort study 154,070 ≥30 0.23 0.11 0.19 - - - 
Heeringa et 
al.140 
(2006) 
Netherlands Prospective cohort study 6,808 ≥55 6.0 5.1 5.5 11.5 8.9 
<60 years:0.7% 
>80 years: 15.4% 
Lake et al.156 
(1989) Australia  1,765 >60 5.6 4.2 4.9 - - - 
Friberg et al.157 
(2003) Denmark 
Prospective 
cohort study 8,606 50-89 3.3 1.1 - - - - 
Chien et al.158 
(2010) China 
Prospective 
cohort study 3,560 ≥35 1.4 0.7 1.1 1.68 0.76 - 
Inoue et al.159 
(2009) Japan 
Retrospective 
cohort study 630,138 ≥40 1.35 0.43 0.56 - - - 
Zhou et al.160 
(2008) China  29,079 ≥30 0.91 0.65 0.77 - - - 
Ohsawa et al.161 
(2007) Japan 
Prospective 
cohort study 9,483 ≥30 0.65 0.62 0.64 - - - 
Jeong et al.162 
(2005) Korea 
Retrospective 
cohort study 14,450 ≥40 1.2 0.4 0.7 - - - 
Saggu et al.163 
(2016) India 
Prospective 
cohort study 4,077 ≥18 0.13 0.27 0.2 - - - 
 
1.4.3 Geographical area 
The vast majority of studies examining the prevalence of AF come from Western 
Europe and North America (table 2). A systematic review of 184 epidemiological 
studies showed that the highest prevalence rates of AF were estimated in North 
America, affecting 925.7/100,000 population in men and 520.8/100,000 population 
in women12. In Sub-Saharan Africa, the prevalence of AF was 659.8/100,000 
population in men and 438.1/100,000 population in women whilst the Asia-Pacific 
region had the lowest prevalence rates, affecting 340.2/100,000 population in men 
and 196.0/100,000 population in women. 
 
Figure 3. Worldwide age-adjusted prevalence rates of atrial fibrillation (per 100,000 
population)12 
 
The incidence of AF followed a similar geographical pattern. North America had the 
highest estimated incidence with rates of 264.5/100,000 person-years in men and 
196.3/100,000 person-years in women. Sub-Saharan Africa was estimated to have 
an incidence rate of 58.4/100,000 person-years in men and 42.7/100,000 person-
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years in women whilst the Asia-Pacific region were estimated to have the lowest 
incidence of AF with rates of 33.8/100,000 person-years in men and 19.8/100,000 
person-years in women. Overall, there was a two-fold higher incidence rate in 
developed countries compared with developing countries and incidence significantly 
increased with age in all geographical areas. 
1.4.4 Ethnicity 
Epidemiological studies have shown that the prevalence of AF within different ethnic 
populations varies significantly. A summary of these studies is found in table 3.  
1.4.4.1 African-American/Black population 
The majority of trials examining the influence of ethnicity on AF originate from North 
America and primarily look at the burden of AF in Caucasians and African-
Americans. Despite African-Americans having a higher prevalence of conventional 
risk factors for AF164-166 as well as a higher incidence of stroke164, they have a 
signficantly lower prevalence of AF compared with Caucasians. For instance, a 
cross-sectional study of 1.89 million adults over the aged of 20 demonstrated an AF 
prevalence of 2.2% in Whites and 1.5% in Blacks (p<0.001)4 whilst in another study 
with 430,317 adults over the age of 60, the prevalence of AF was 8.0% in Whites 
and 3.8% in Blacks167.  A lower rate of AF has also been noted in black patients with 
heart failure (38.3% in Whites vs. 19.7% in Blacks, p<0.001)168 and following 
cardiac surgery (35% in Whites vs. 22% in Blacks, p<0.001)169.  
The reason for this is uncertain although some theories have been proposed. It was 
previously thought that the reduced prevalence of AF in African-Americans was in 
fact caused by under-detection of the arrhythmia due to African-Americans having 
less access to healthcare170 and being more likely to suffer from paroxysmal AF171. 
However, a recent study which involved the interrogation of pacemakers in African-
Americans and white-Americans found that during 3.7 (±1.8) years of follow-up, 
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rates of AF were consistently lower in African-Americans172. This would seem to 
indicate that potential underreporting of AF does not account for the disparity 
between the two ethnic groups. 
The black population appears to have smaller atria in comparison to Caucasians173, 
174 with one study showing that in multivariate analyses, left atrial (LA) dimension in 
black males was 1.9mm less than in white males173. Genetics may also play a role. 
A study by Marcus et al175 showed that the African-American risk of developing AF 
increased with increasing levels of European ancestry whilst Roberts et al176 
identified an SNP, rs10824026 on chromosome 10q22, which was significantly more 
common among African-Americans than Caucasians and is known to be protective 
against AF. It is therefore possible that the variation in AF prevalence between 
African-Americans and Caucasians is a consequence of both environmental and 
genetic factors.
 Table 3. Literature review of AF prevalence based on ethnicity 
Author (year) Study location Study design Participants 
Age 
range 
(years) 
Prevalence based on ethnicity 
White  
(%) 
Black  
(%) 
South 
Asian (%) 
East 
Asian (%) 
Asian  
(%) 
Hispanic  
(%) 
Rader et al.169 
(2011) USA 
Retrospective cohort study of 
cardiac surgery patients 23,524 
62.5 
(mean) 35 22 - - - - 
Shen et al.167 
(2010) USA Cross-sectional study 430,317 ≥60 8.0 3.8 - - 3.6 3.9 
Marcus et al.174 
(2010) USA Meta-analysis of 3 cohorts 6,611 
74.0 
(mean) 5 1 - - - - 
Haywood et al.177 
(2009) USA Prospective cohort study 39,056 - 1.34 0.59 - - - - 
Borzecki et al.178 
(2008) USA Health survey 664,754 - 5.7 3.4 - - 3.6 3.0 
Khairallah et al.179 
(2004) USA 
Retrospective study of AF-
related hospital admissions 2,018,578 
71.1 
(mean) 71.5 5.6 - - - - 
Ruo et al.168 
(2004) USA 
Retrospective study of heart 
failure admissions 1,373 
73.0 
(mean) 38.3 19.7 - - - - 
Upshaw et al.180 
(2002) USA Retrospective cohort study 2,123 20-99 7.8 2.5 - - - - 
Go et al.4 
(2001) USA Cross-sectional study 1,890,000 >20 2.2 1.5 - - - - 
Sacco et al.181 
(2001) USA 
Prospective study of stroke 
patients 1,844 
70.0 
(mean) 8 5 - - - 4 
Gillott et al13 
(2017) UK Cross-sectional study 417,575 ≥18 2.43 - 0.46 - - - 
Mathur et al.182 
(2013) UK Cross-sectional study 6,292 ≥18 1.2 0.4 0.2 - - - 
Gunarathne et al.183 
(2008) UK 
Retrospective study of stroke 
admission 3,083 
74.7 
(mean) 34.8 9.0 11.8 - - - 
Markus et al.184 
(2007) UK 
Prospective study of stroke 
admissions 1,200 
69.2 
(mean) 32.4 11.2 - - - - 
Newton et al.10 
(2005) UK 
Retrospective study of heart 
failure admissions 528 
69.0 
(mean) 31 - 15 - - - 
Conway et al.9 
(2003) UK 
Retrospective study of stroke 
admissions 832 
74.0 
(mean) 13 3 1 - - - 
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Table 3. Literature review of AF prevalence based on ethnicity (continued) 
Author (year) Study location Study design Participants 
Age 
range 
(years) 
Prevalence based on ethnicity 
White  
(%) 
Black  
(%) 
South 
Asian (%) 
East 
Asian (%) 
Asian  
(%) 
Hispanic  
(%) 
Saggu et al.163 
(2016) India Prospective cohort study 4,077 ≥18 - - 0.2 - - - 
Hingorani et al.185 
(2012) India Retrospective cohort study 3,978 18-76 - - 0.03 - - - 
Kaushal et al.186 
(1995) Nepal Prospective cohort study 984 ≥18 - - 0.1 - - - 
Chen et al.187 
(2011) China Cross-sectional study 9,309 >20 - - - 0.9 - - 
Long et al.188 
(2011) China Cross-sectional study 20,430 ≥50 - - - 0.8 - - 
Chien et al.158 
(2010) China Prospective cohort study 3,560 ≥35 - - - 1.1 - - 
Zhou et al.160 
(2008) China Cross-sectional study 29,079 30-85 - - - 0.77 - - 
Yap et al.189 
(2007) Singapore 
Population-based study of 
Chinese residents 1,839 ≥55 - - - 1.5 - - 
Inoue et al.159 
(2009) Japan Retrospective cohort study 630,138 ≥40 - - - 0.56 - - 
Iguchi et al.190 
(2008) Japan Retrospective cohort study 41,436 
72.1 
(mean) - - - 1.6 - - 
Ohsawa et al.161 
(2007) Japan Prospective cohort study 9,483 ≥30 - - - 0.64 - - 
Lee et al.191 
(2008) Korea Retrospective cohort study 10,012 40-69 - - - 0.4 - - 
Jeong et al.162 
(2005) Korea Retrospective cohort study 14,450 ≥40 - - - 0.7 - - 
Lim et al.192 
(2016) Malaysia Cross-sectional study 10,805 
52.6 
(mean) - - - 0.54 - - 
Kiatchoosakun et al.193 
(1999) Thailand Health survey 8,791 - - - - 0.36 - - 
Dewhurst et al.194 
(2012) Tanzania Cross-sectional study 2,232 ≥70 - 0.67 - - - - 
Connor et al.195 
(2005) 
South 
Africa 
Multicentre observational 
study 9,731 
50.7 
(mean) 5 2 - - 2 - 
1.4.4.2 Other ethnicities 
Outside of the Western World, the majority of data originate from East Asia. There 
are a number of population-based studies from China which demonstrate an AF 
prevalence of between 0.77% and 1.1%158, 160, 187, 188. In Japan, the AF prevalence 
rate ranges between 0.56% and 1.6%159, 161, 190 whilst in Korea AF rates have been 
shown to be between 0.4 and 0.7%162, 191. Single cross-sectional studies in Malaysia 
and Thailand have revealed an AF prevalence of 0.54 and 0.36%192, 193.  
Elsewhere, an observational study of elderly Tanzanians (above 70 years of age) 
found an AF prevalence of just 0.67%194. And a multicentre study in South Africa 
demonstrated a 2% prevalence of AF in Black-Africans and Asians compared with a 
5% AF prevalence in White-Africans195. 
Compared with an AF prevalence of around 3% that is seen in Caucasian 
populations living in North America and Europe3, these findings indicate a 
significantly lower prevalence of AF in East Asian and Black populations. 
 
1.5 South Asian population and atrial fibrillation 
The South Asian population is a diverse ethnic group which comprises more than a 
fifth of the world’s population and originates from the Indian sub-continent, 
incorporating the countries of India, Pakistan, Bangladesh, Sri Lanka, Nepal and 
Bhutan. This ethnic group is consistently shown to have a high prevalence of 
established risk factors for the development of AF but despite this risk profile, they 
too have been shown to have lower rates of AF9-11, 13.  
1.5.1 Risk factors for atrial fibrillation in South Asians 
The most notable risk factor disparity in South Asians is found in the occurrence of 
diabetes mellitus and impaired glucose tolerance.  A study assessing the national 
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burden of cardiovascular disease in the UK  found a two-fold higher prevalence of 
diabetes mellitus in South Asian men (8.5% vs. 4.3%) and women (6.6 vs 3.4%) 
compared with the general population196. Similar results were noted in a Canadian 
population with a prevalence of 8.1% in South Asians versus 4.2% in Whites 
(P<0.001)197. Related conditions of metabolic syndrome (a combination of impaired 
glucose homeostasis, insulin resistance, abdominal obesity, hypertension, reduced 
HDL-cholesterol and elevated triglycerides) and obesity are also significantly higher 
in South Asians. A large multi-ethnic population-based study found that the 
prevalence of the metabolic syndrome was 46.3% in South Asian men (vs. 18.8% in 
European men, p<0.0001) and 30.8% in South Asian women (vs. 9.1% in European 
women, p<0.0001)198. The definition of obesity varies depending upon the 
anthropometric measure used (BMI, waist:hip ratio, body fat percentage). Most 
studies show that in comparison to Caucasians, South Asians have a similar or 
lower BMI and yet interestingly, the same studies demonstrate higher levels of 
visceral fat and higher body fat percentage199, 200. For instance, in a cross-sectional 
analysis of two multi-ethnic studies, BMI was 25.8 in South Asians and 27.8 in 
Caucasians (P<0.001) and yet South Asians had higher levels of hepatic and 
intermuscular fat and lower lean body mass199. South Asians are also more 
susceptible to OSA. In a study of patients attending a weight loss service in the UK, 
the prevalence of OSA was 85% in South Asians versus 66% in White Europeans 
(p= 0.017) and South Asians were more likely to have severe OSA (42.5% vs. 
21.6%, p= 0.015). 
Hypertension appears to be more prevalent in South Asians. A Canadian 
population-based study comparing South Asians with Caucasians demonstrated a 
prevalence of 17.0% and 13.7% respectively (p<0.001)197. More specifically, there is 
evidence that South Asians have higher resting systolic (124±17 vs. 122±16mmHg, 
p<0.001), diastolic (80±10 vs. 77±11mmHg, p<0.001) and mean arterial pressures 
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(95±12 vs. 92±12mmHg, p<0.001)201. However, the picture may be more complex 
and hypertension rates may vary within South Asian groups. A systematic review of 
12 studies found that in comparison with Caucasians, blood pressure was higher in 
Indians, marginally lower in Pakistanis and significantly lower in Bangladeshis202.  
 
Figure 4. Common risk factors for AF and their prevalence in South Asians vs. 
Caucasians (where applicable)9, 10, 136, 198, 203-206 
It is well known that South Asians have a heightened risk of coronary artery disease 
with prevalence rates more than double that of Caucasians. In one population-
based study the prevalence of coronary disease was 10.7% in South Asians versus 
4.6% in Europeans (p=0.001)203. South Asians also have a higher burden of 
premature coronary disease207, more severe coronary artery disease208, twice the 
hospitalisation rate from coronary disease209 and a significantly higher mortality rate 
from the condition compared with Caucasians210. 
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The prevalence of heart failure appears comparable between South Asians and 
other ethnicities (1.2% in South Asians211 compared with UK national average of 
1.6%212) although is perhaps less than anticipated given the high rates of 
cardiovascular disease. However, there is evidence to suggest that South Asians 
are significantly younger at the time of first hospitalisation for heart failure and it has 
been postulated that this may be a reflection of the higher prevalence of premature 
coronary artery disease207, 213. 
Studies have consistently shown that South Asians have a lower alcohol 
consumption (alcohol consumption ≥once/week: South Asian countries 10.7% vs. 
other countries 26.9%)214, 215. This was believed to relate to religious and cultural 
differences between South Asians and other ethnicities. However, this may be an 
incorrect assumption and drinking habits are likely to vary widely between different 
South Asian groups. For example, alcohol-related deaths are higher amongst Indian 
men compared with the general population and alcohol intake in Indian women has 
consistently increased in recent years. Conversely, individuals from Bangladesh and 
Pakistan are less likely to drink alcohol although Pakistani men who drink tend to 
consume more alcohol than other minority ethnic groups216. This reflects the diverse 
nature of the South Asian population. 
Physical activity levels are significantly lower in South Asians compared with 
Caucasians (973 vs. 1465 metabolic equivalents of task [MET] /minute, p<0.001)217, 
218. A UK population-based study found that exercise levels were significantly lower 
in South Asians across gender, age groups, South Asian sub-groups and were 
independent of socioeconomic and geographical factors217. 
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1.5.2 Prevalence of atrial fibrillation in South Asians 
Despite a high burden of cardiovascular risk factors, South Asians have a 
significantly lower prevalence of AF. The West Birmingham Stroke Project9, a 
registry data review of 832 consecutive patients admitted with non-haemorrhagic 
stroke over a 2 year period demonstrated that patients of Indo-Asian origin had 
significantly higher rates of hypertension (44% vs 34%, p<0.001) and diabetes 
mellitus (41% vs. 15%, p<0.001) but an AF rate of only 1% (compared with 13% in 
the Caucasian group). A study in 2005 by Newton et al compared South Asian- and 
white- cohorts who were admitted acutely to hospital with a first presentation of 
heart failure10. Again, this study demonstrated higher rates of hypertension (45% vs. 
33%) and diabetes (46% vs. 18%) in South Asians but with a significantly lower rate 
of AF (15% vs. 31%). A recent population-based study of 417,575 primary care 
records showed that AF prevalence was 2.43% in Caucasians and 0.46% in South 
Asians (p<0.001) despite a higher frequency of hypertension, diabetes mellitus and 
coronary artery disease13. These findings were further supported by a review of 
98,982 clinical records of patients within the Heart of Birmingham Primary Care 
Trust in 2009/201011; despite higher rates of diabetes mellitus, hypertension and 
coronary heart disease, patients of South Asian origin had a significantly lower 
prevalence of AF compared to those of white ethnicity. 
1.5.3 Reasons for the low prevalence of atrial fibrillation in 
South Asians 
The reason for the lower AF prevalence in South Asians is uncertain. Could it simply 
be due to an under-detection of the arrhythmia in the South Asian population, as 
was thought with African-Americans? In the UK, there is certainly evidence to show 
that South Asians are less likely to engage with medical services. For example, 
colorectal, breast and cervical cancer screening programmes all show a significantly 
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lower uptake within this ethnic group219, 220, they are less likely to access or regularly 
attend antenatal care221 and dementia services are not accessed until the condition 
is very advanced222. Although this might explain the variation in AF prevalence in 
epidemiological studies involving GP records, it would not account for the lower 
prevalence of AF seen in South Asian patients admitted acutely with non-
haemorrhagic stroke or heart failure9, 10. Therefore other factors must be involved 
and there is limited evidence to suggest that South Asians have physiological 
variations in atrial morphology, electrophysiology and autonomic tone which in turn, 
may influence their risk of developing AF. 
1.5.3.1 Cardiovascular morphology 
South Asians appear to have smaller atria. A study by Chahal et al examined 458 
patients of either Indo-Asian or European-White origin and assessed for differences 
in cardiac structure using echocardiography223. They found that those of Indo-Asian 
origin had smaller left atrial volumes (25.0±7.7 ml vs. 30.8±10.4 ml), even after 
indexing for body surface area (14.2±4.0 ml/m2 vs. 16.3±4.8 ml/m2) and lean body 
mass (5.3±1.6 g/kg vs. 5.8±1.7 g/kg). More recently, the EchoNoRMAL study was 
designed to provide reference values for standard echocardiographic 
measurements from geographically diverse population studies and included data 
from 22,404 adult volunteers, 1,751 of whom were South Asian224. The authors 
found that the upper reference values for left atrial diameter were lowest in the 
South Asian and African-Black populations and highest in the European and 
American-Black populations, even when indexed to body surface area.  
South Asians not only have smaller atria but there is also evidence to suggest that 
they are of a smaller stature in general. They are shorter in comparison to the 
general UK population225, have lower body surface area206, smaller left ventricular 
(LV) size and volume224 and smaller coronary226, 227 and radial arteries228. However, 
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even when indexed for body size, the cardiac chamber size remains smaller in the 
SA population, suggesting that their overall heart size is relatively smaller.  
The reason for this remains poorly understood but it is likely that genetic differences 
play a major role. Hur et al examined variations in height, weight and BMI between 
Caucasian and East Asian adolescent twins229. They found that Caucasian twins 
were taller, heavier and had higher BMIs compared to their East Asian counterparts 
and concluded that these differences were predominantly related to genetic rather 
than environmental factors. A more recent study by Wilde et al assessed the height 
of South Asian children living in the Netherlands and compared these results with 
the heights of Dutch children and South Asian children living in affluent parts of 
India230. They found that South Asian children living in the Netherlands were 
marginally taller than those in India but that Dutch children were consistently taller 
than their South Asian contemporaries at every age. They, too, concluded that the 
disparity in height between the ethnic groups was more likely to be related to 
genetic factors given that the environmental factors were similar between South 
Asian and Dutch children living in the Netherlands. 
1.5.3.2 Atrial electrophysiology 
Limited evidence currently exists with regard to variations in cardiac 
electrophysiology in South Asians. Two studies have examined South Asian 
electrocardiographic measurements non-invasively231, 232 using standard 12-lead 
electrocardiograms (ECGs). Overall they found that in comparison with Caucasians, 
South Asian QRS duration (males: 87.08 vs 93.75ms, p<0.001; females: 82.07 vs. 
86.07ms, p= 0.002) and corrected QT intervals (males: 390.07 vs. 403.88ms, 
p<0.001; females: 405.68 vs. 410.80, p,0.001) were shorter. There have been no 
studies which have invasively assessed intracardiac electrogram or conduction 
intervals. 
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In addition to a lower rate of AF, there is some evidence that South Asian ethnicity 
influences the prevalence of other arrhythmias. A recent observational study found 
that pacemaker implantation rates were significantly lower in South Asians with a 
crude incidence of 1.07/1,000 population compared with 6.15/1,000 population in 
Caucasians, suggesting a reduced susceptibility to bradycardias233. There is also a 
single study demonstrating a higher incidence of ventricular arrhythmias in South 
Asian patients with heart failure213. These findings would support the hypothesis that 
South Asians have variations in cardiac electrophysiology in comparison with 
Caucasians. 
1.5.3.3 Autonomic nervous system 
There is limited evidence to suggest that South Asians may also have variations in 
autonomic tone. Bathula et al measured heart rate variability (HRV) and baroreflex 
sensitivity in a sample of Indian-Asians and Europeans234. They found that Indian-
Asians had lower mean R-R intervals (969 vs. 1,022ms, p= 0.002), less HRV (total 
RR interval power 925 vs. 1,224ms2, p= 0.008) and reduced baroreflex sensitivity 
(5.7 vs. 6.6mmHg, p=0.01) compared with Europeans. They concluded that Indian-
Asians may have variations in autonomic function with less vagal tone and 
increased sympathetic activity. This would explain the higher resting heart rate that 
is consistently seen in both South Asian children and adults compared with 
Caucasian counterparts235-237. However, as South Asian autonomic function has 
only been assessed in a single study, further research is required to confirm these 
findings. 
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1.5.4 Assessment of potential physiological variations in 
South Asians 
A range of non-invasive investigations can be used to evaluate for differences in 
South Asian atrial morphology, atrial electrophysiology and autonomic tone. These 
techniques are summarised in the following sections. 
1.5.4.1 Assessment of atrial morphology 
Left atrial volume can be assessed with a range of imaging techniques. These 
include echocardiography, as demonstrated above, and multi-slice computed 
tomography. However, cardiovascular magnetic resonance imaging (MRI) is 
considered the most accurate technique for the non-invasive assessment of atrial 
volumes due to the high spatial resolution and excellent myocardial border 
definition238.  
Although South Asian atrial size has previously been assessed with 
echocardiography223, 224, no data currently exist with regards to South Asian atrial 
size using the reference technique of cardiovascular MRI. Additionally, it is not 
known whether atrial function differs between South Asians and Caucasians. 
1.5.4.2 Assessment of atrial electrophysiology 
Although it is possible to assess atrial electrophysiology invasively with the use of 
diagnostic catheters at the time of a cardiac electrophysiology study, this approach 
carries procedural risks such as vascular injury, haemorrhage, cardiac perforation 
and thromboembolism239. As a consequence, it is not commonly used as a research 
tool to assess cardiac electrophysiology in healthy subjects. 
Atrial electrophysiology can alternatively be assessed non-invasively. P wave 
indices are measurements derived from standard 12-lead ECGs which can quantify 
atrial electrophysiological function. They can reflect atrial remodelling and 
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differences in a range of P wave indices have been shown to be associated with the 
development of AF240. 
• P wave duration 
P wave duration (figure 5) is defined as the time between the P wave onset 
(intersection point of the upward deflection of the P wave in relation to the isoelectric 
line) and offset (intersection point of the downward deflection of the P wave in 
relation to the isoelectric line). It is a marker of intra- and inter-atrial conduction 
time241. Maximum P wave duration has been shown to be significantly higher in 
patients with idiopathic paroxysmal AF compared with control subjects242 and has 
been shown to be a risk factor for AF, independent of hypertension and BMI243. 
Interestingly, significantly lower minimum P wave duration has also been found in 
idiopathic paroxysmal AF patients241 and hypertensive patients with paroxysmal 
AF244 in comparison with controls, suggesting that extremes of P wave duration are 
important in predicting AF risk. This is supported by a population-based ECG study 
of 285,933 individuals which found that very short (≤89ms, HR 1.60), intermediate 
(112-119ms, HR 1.22), long (120-129ms, HR 1.50) and very long (≥130ms, HR 
2.06) median P wave duration was associated with an increased risk of incident 
AF245. 
• P wave dispersion 
P wave dispersion is defined as the difference between the maximum and minimum 
P wave duration measured on a 12-lead ECG. It reflects inhomogeneous and 
discontinuous propagation of sinus impulses. P wave dispersion has been shown to 
be significantly higher in patients with paroxysmal of AF compared with control 
subjects242, 246. In one study, a P wave dispersion of 40ms separated patients from 
controls with a sensitivity of 83%, a specificity of 85% and a positive predictive 
accuracy of 89%242. P wave dispersion is able to predict recurrence of AF following 
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cardioversion247, 248 and can determine which patients with hypertension are at risk 
of developing AF244. 
• P wave amplitude 
P wave amplitude (figure 5) is defined as the measurement between the wave’s 
peak, or nadir, to the isoelectric line. It is indicative of the direction of atrial 
depolarisation and atrial myocardial mass and is believed to reflect the degree of 
atrial electro-anatomical remodelling249. Increased P wave amplitude has been 
shown to be independently associated with the development of new-onset AF250 
whilst reduced P wave amplitude of <0.1mV has been found to independently 
predict clinical recurrence of AF following radiofrequency catheter ablation249. 
• P wave terminal force 
P wave terminal force in lead V1 (PWTF-V1, figure 5)  of a standard 12-lead ECG is 
defined as the product of the duration and the amplitude of the negative terminal 
portion of the P wave in lead V1251. It is a specific indicator of left atrial size252 and 
correlates with left heart filling pressures253, 254. Increased PWTF-V1 is associated 
with a 1.9-fold increase in the risk of AF255, 256. 
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Figure 5. P wave duration, P wave amplitude and P wave terminal force in lead V1 
(PWTF-V1) 
1.5.4.3 Assessment of the autonomic nervous system 
Due to the complex nature of the autonomic nervous system, there is currently no 
single test which can precisely evaluate its function. Instead, multiple different 
methods are needed to assess parasympathetic and sympathetic activity. The 
majority of investigations which are used to assess autonomic function evaluate 
cardiovascular reflexes which are triggered by performing specific, provocative 
manoeuvres. In the past, Ewing’s battery of tests was performed, including heart 
rate responses to deep breathing, to standing and to the Valsalva manoeuvre and 
blood pressure responses to active standing and to sustained hand grip257. 
However, in recent years, HRV has evolved to become the most widely used non-
invasive tool to assess autonomic tone. 
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HRV is a measure of heart rate fluctuations between consecutive normal-to-normal 
(NN) heartbeats (figure 6). Since heart rate is modulated by the autonomic nervous 
system, HRV is believed to reflect activity within the sympathetic and 
parasympathetic branches. Variations in heart rate can be evaluated using time-
domain indices, which quantify the amount of variability in an unordered set of NN 
intervals, or frequency-domain indices, which distributes ordered NN intervals into 
different frequency bands. The commonly used variables are shown in table 4. 
 
Figure 6. Variation in sinus rate 
 
Time-domain indices are the simplest way of calculating heart rate variability. The 
commonest of these indices is the standard deviation of all N-N intervals (SDNN) 
which is a reflection of all cyclic components responsible for variability during the 
recording period. Both sympathetic and parasympathetic activity contribute to SDNN 
and it is a representation of total HRV258. Other commonly used indices include the 
standard deviation of the average N-N interval for each 5-minute segment of a 24-
hour recording (SDANN) which provides information about external influences on 
HRV such as circadian variation and physical activity; and the square root of the 
mean of the sum of the squares of differences between adjacent N-N intervals 
(RMSSD) which is a marker of beat-to-beat variation mediated by vagal activity258. 
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The calculation of frequency-domain indices is more complex and involves spectral 
techniques to convert each N-N interval into its corresponding frequency and 
quantify its relative intensity (power). This is commonly achieved using the fast 
Fourier transform method and four main spectral components are typically 
calculated: ultra-low frequency (ULF), very-low-frequency (VLF), low-frequency 
(LF), and high-frequency (HF).  Signal within the VLF band reflects sympatho-vagal 
balance and is influenced by the renin-angiotensin system259; signal within the LF 
band can be produced by both parasympathetic and sympathetic activity260; and 
signal within the HF band reflects parasympathetic activity260. The ratio of LF to HF 
power has previously been used to measure sympatho-vagal balance with a low 
LF:HF reflecting parasympathetic predominance and a high LF:HF reflecting 
sympathetic predominance261. There is currently no consensus regarding the 
specific physiological process which generates the ULF band although very slow-
acting biological processes such as circadian variation, thermoregulation, 
metabolism and the renin-angiotensin system are implicated260. 
Changes in heart rate variability have been shown to be associated with AF. A study 
of 57 patients with paroxysmal AF found that immediately prior to the onset of AF, 
most patients with structurally normal hearts had increased vagal tone (increased 
HF and reduced LF:HF ratio) whilst those with structural heart disease typically had 
increased sympathetic activity (decreased HF and increased LF:HF ratio)49. A study 
which assessed 93 patients who had recently undergone DC cardioversion for AF 
found that those with increased sympathetic and reduced vagal modulation 
(increased LF:HF ratio) were at significantly higher risk of early AF recurrence262. 
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Table 4.  Heart rate variability indices263 
 
Variable Definition Physiological correlation 
Time-domain indices 
SDNN Standard deviation of all NN 
intervals 
Represents total HRV 
SDANN Standard deviation of averages of 
NN intervals for each 5-minute 
segment of a 24-hour recording 
Reflects sympathetic 
activity 
SDNN index Mean of standard deviations of all 
NN intervals for each 5-minute 
segment of a 24-hour recording 
Reflects autonomic 
influence on HRV 
RMSSD Square root of the mean of the sum 
of the squares of differences 
between adjacent NN intervals 
Reflects 
parasympathetic activity 
Triangular index Intergral of the density distribution 
divided by the maximum of the 
density distribution 
Represents total HRV 
Frequency domain indices 
Very low frequency 
(VLF) 
Power in the very low frequency 
(0.003-0.04 Hz) range 
Reflects sympatho-vagal 
balance 
Low frequency (LF) Power in the low frequency  
(0.04-0.15 Hz) range 
Reflects sympathetic and 
parasympathetic activity 
High frequency (HF) Power in the high frequency  
(0.15-0.4 Hz) range 
Reflects 
parasympathetic activity 
LF/HF ratio Ratio of LF to HF Reflects sympatho-vagal 
balance 
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1.6 Aims of the thesis 
There is evidence to suggest that South Asians have a lower burden of AF in 
comparison to Caucasians despite a suffering from a higher prevalence of 
established risk factors. The reason for this disparity remains uncertain however. It 
is possible that the lower prevalence of AF is simply due to an under-detection of 
the arrhythmia caused by South Asians engaging less with medical services. 
Alternatively, South Asians may have differences in atrial morphology, atrial 
electrophysiology, autonomic function or anthropometry compared with Caucasians 
and these variations may confer protection against the development of AF. 
The subsequent chapters of the thesis each have a specific aim with individual 
introduction, methods, results and discussion: 
Chapter 2: To investigate the incidence of subclinical AF in a retrospectively 
selected cohort of South Asian and Caucasian patients receiving an implanted 
cardiac device. 
Chapter 3: To compare atrial morphology and function in South Asians and 
Caucasians using the reference technique of cardiovascular magnetic resonance 
imaging. 
Chapter 4: To evaluate baseline electrocardiographic and intracardiac conduction 
intervals in a retrospectively selected cohort of South Asian and Caucasian patients 
undergoing invasive electrophysiology studies. 
Chapter 5: To assess P-wave indices, left atrial size, supraventricular ectopy, heart 
rate variability, exercise capacity and anthropometry in a prospectively selected 
cohort of South Asian and Caucasian healthy volunteers. 
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Chapter 2. Incidence of subclinical atrial 
fibrillation in a South Asian population 
2.1 Abstract 
Background:   South Asians have a lower prevalence of atrial fibrillation (AF) 
compared with Caucasians despite higher rates of conventional risk factors and a 
higher incidence of stroke. It is not clear whether South Asians truly experience less 
AF or whether this is due to under-detection of the arrhythmia. Therefore, the 
researcher aimed to determine whether South Asian patients with pacemakers have 
a lower incidence of device-detected subclinical episodes of AF compared with 
Caucasian controls. 
Methods:   A retrospective cohort study of South Asian and Caucasian patients 
who underwent pacemaker implantation between 2006 and 2016 was performed. 
Subclinical AF episodes detected during subsequent device clinic follow-up visits 
were identified and the occurrence of clinical AF, cerebrovascular events and all-
cause mortality was recorded. 
Results:   A total of 5,648 patients underwent pacemaker implantation at the 
Yorkshire Heart Centre, UK, during the study period. Of these 169 were South 
Asian and 72 met the eligibility criteria. The cumulative incidence of subclinical AF 
was significantly lower in South Asians compared with Caucasians (log rank 
p=0.002) with an annual event rate of 6.9% versus 13.9%, and South Asian 
ethnicity was an independent predictor of a lower incidence of subclinical AF (OR 
0.43; 95% CI 1.01-5.38).  
Conclusions:   South Asians with an implanted pacemaker have a lower rate of 
subclinical AF compared with Caucasians.  
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2.2 Introduction 
The reduced prevalence of AF that is seen in South Asians may simply be a 
consequence of an under-detection of the arrhythmia within this ethnic group rather 
than a lower susceptibility to the condition. There is evidence to suggest that South 
Asians have less engagement with medical services219-221. As a consequence, 
episodes of AF may not be identified and recorded and the true occurrence of AF 
within South Asians may not be known. 
Improvements in pacemaker technology now enable these devices to detect and 
record atrial arrhythmias and act as long-term cardiac rhythm monitors. Subclinical 
AF, defined as an asymptomatic atrial high rate episode (AHRE) at a rate of more 
than 190 beats per minute for more than six minutes 264, has been associated with 
the development of clinical AF, stroke and death265, 266. 
The city of Leeds, England, has a population of 751,485, 5.98% of whom are of 
South Asian descent267. It is therefore an ideal setting to compare South Asians and 
Caucasians whilst minimising potential bias from confounding environmental 
factors.  
The aim of this study was to investigate the incidence of subclinical AF in a 
retrospectively selected cohort of South Asian and Caucasian patients receiving a 
cardiac implantable electronic device (CIED). The hypothesis was that South Asians 
would be less susceptible to asymptomatic AHREs and have a lower incidence of 
subclinical AF. 
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2.3 Methods  
2.3.1 Study population 
A single centre retrospective cohort study was performed examining de novo dual-
chamber pacemaker and cardiac resynchronisation therapy pacemaker 
implantations at the Yorkshire Heart Centre, Leeds Teaching Hospitals NHS Trust, 
between 1st January 2006 and 31st December 2016. Patients were identified 
retrospectively from the local cardiac device database and every South Asian 
patient was considered for enrolment in the study. Caucasian controls were defined 
as the subsequent Caucasian patient located in the database that followed the 
South Asian subject and who was a match for age, gender and type of device. 
Patients were excluded if they had a history of atrial arrhythmia, if CIED follow-up 
was performed at a different centre, if no atrial lead was present or if they had 
congenital heart disease.  
Ethnicity was identified using information from the NHS Patient Administration 
System. Patients are routinely asked to define their ethnicity during clinic visits and 
this is categorised using 18 national Ethnic Category codes, as used in the 2001 
and 2011 census267. Based upon the definition of South Asia rendered by the United 
Nations268, patients who had self-reported their ethnicity as Indian, Pakistani, 
Bangladeshi, Sri Lankan, Nepalese, Maldivian or Bhutanese were classified as 
South Asian. Patients who had self-reported their ethnicity as White British were 
defined as Caucasian. 
The records of every CIED clinic visit were analysed for each subject and the date 
and occurrence of every subclinical AF episode (defined as an AHRE of >190 beats 
per minute, lasting for more than six minutes264) was recorded. The interrogation 
report for each visit documented the date, time and duration of every AHRE 
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recorded and every device had a preset AHRE detection rate of more than 190 
beats per minute. Electronic patient records were screened to obtain information on 
patients’ co-morbidity and medication history and for the occurrence of clinical AF, 
stroke or transient ischaemic attack (TIA) or death. 
The study was reviewed by the Research and Innovation Department at Leeds 
Teaching Hospitals NHS Trust and approved as a Service Evaluation Project. 
2.3.2 Study outcomes 
The primary outcome of this study was the incidence of subclinical AF identified on 
CIED interrogation. Secondary outcomes included the incidence of clinical AF, 
cerebrovascular events and all-cause mortality in South Asian subjects. Clinical AF 
was defined as a cardiology clinic or hospital discharge diagnosis of AF. 
Cerebrovascular events were defined as a neurology clinic or hospital discharge 
diagnosis of stroke or TIA. 
2.3.3 Statistical analysis 
Statistical analysis was performed using SPSS (IBM SPSS Statistics Version 22.0, 
IBM Corporation, Armonk, New York). Normality of data was tested using a Shapiro-
Wilk test. Continuous variables were expressed as mean ± SD if normally 
distributed or median (interquartile range [IQR]) if non-normally distributed. Student t 
test or Mann Whitney U test were used to compare continuous variables depending 
on normality. Categorical variables were expressed as percentages and compared 
using Pearson’s chi-square test. 
Kaplan-Meier survival statistics were used to assess the cumulative incidence of 
sub-clinical AF in South Asians and Caucasians and were compared with the use of 
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a log-rank test. Subjects entered observation at the time of their CIED implantation 
and were censored at the time of an outcome or their last follow-up attendance. 
Predictors of subclinical AF were assessed using logistic regression analysis. In the 
multivariable analysis for assessing the presence of subclinical AF, the model was 
adjusted for age, gender, ethnicity, hypertension, diabetes mellitus and ischaemic 
heart disease. Hazard ratios with corresponding 95% confidence intervals were 
calculated using binomial logisitic regression. P-values of less than 0.05 were 
considered statistically significant. For the long-term clinical outcomes analysis, 
annual event rates (%/year) were calculated as the number of events per patient-
years of follow-up and compared using Pearson’s chi-square test. 
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2.4 Results 
2.4.1 Study cohort 
A total of 5,648 pacemaker and cardiac resynchronisation therapy device 
implantations were performed at the Yorkshire Heart Centre during the study period 
and 169 patients were of South Asian ethnicity. Of these, 97 patients were excluded 
as shown in figure 7, leaving a final South Asian cohort of 72 patients which were 
matched with Caucasian controls.  
 
Figure 7. Flow chart of ethnic distribution of pacemaker insertions at the Yorkshire 
Heart Centre between 2006 - 2016 
  
-49- 
 
2.4.2 Baseline characteristics 
Baseline characteristics of study participants are summarised in table 5. South 
Asian patients had a higher prevalence of hypertension, diabetes mellitus and 
ischaemic heart disease. The prevalence of structural heart disease and previous 
thromboembolic events were similar amongst the two ethnic groups and there was 
no significant difference in the length of CIED clinic follow-up. In association with the 
higher prevalence of hypertension, the use of angiotensin converting enzyme (ACE) 
inhibitors, diuretics and aldosterone antagonists were also higher in South Asians. 
There was no significant difference in the use of these medications in South Asian 
and Caucasian patients with heart failure (p=0.251 for ACE inhibitors, p=0.216 for 
diuretics and p=0.09 for aldosterone antagonists). 
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Table 5.   Baseline characteristics 
 South Asian Caucasian P-value 
N 72 72 * 
Age 74.4±10.9 74.5 ± 11.0 0.951 
Female gender, n [%] 38 [52.7] 38 [52.7] 1.000 
Dual-chamber pacemaker, n [%] 52 [72.2] 52 [72.2] 1.000 
Biventricular pacemaker, n [%] 20 [27.8] 20 [27.8] 1.000 
Length of follow-up, days 1196 (1506) 1169 (1233) 0.999 
Left atrial size, mm 39.5±6.8 40.1±5.9 0.611 
Mild LVSD, n [%] 12 [16.7] 10 [13.9] 0.643 
Moderate LVSD, n [%] 14 [19.4] 15 [20.8] 0.835 
Severe LVSD, n [%] 14 [19.4] 13 [18.1] 0.831 
Aortic valve disease, n [%] 11 [15.2] 5 [6.9] 0.113 
Mitral valve disease, n [%] 10 [13.9] 10 [13.9] 1.000 
Hypertension, n [%] 50 [69.4] 33 [45.8] 0.004 
Diabetes mellitus, n [%] 44 [61.1] 13 [18.1] <0.001 
Previous stroke/TIA, n [%] 9 [12.5] 9 [12.5] 1.000 
Venous thromboembolism, n [%] 2 [2.8] 2 [2.8] 1.000 
Ischaemic heart disease, n [%] 35 [48.6] 23 [31.9] 0.042 
Peripheral arterial disease, n [%] 2 [2.8] 2 [2.8] 1.000 
Chronic kidney disease stage III-V, n[%] 25 [34.7] 32 [44.4] 0.233 
Average CHA2DS2VASc score 4.9±1.9 3.7±1.4 <0.001 
Medication 
ACE-i/ARB, n [%] 48 [66.7] 30 [41.7] 0.003 
Beta-blocker, n [%] 30 [41.7] 28 [38.9] 0.735 
Calcium-channel blocker, n [%] 17 [23.6] 12 [16.7] 0.301 
Diuretic, n [%] 34 [47.2] 21 [29.2] 0.026 
Aldosterone antagonist, n [%] 12 [16.7] 3 [4.2] 0.014 
Digoxin, n [%] 2 [2.8] 0 [0] 0.156 
Statin, n [%] 48 [66.7] 38 [52.8] 0.090 
Antiplatelet, n [%] 49 [68.1] 43 [59.7] 0.300 
Anticoagulation, n [%] 2 [2.8] 2 [2.8] 1.000 
Pacemaker implant indication 
Sinus node dysfunction 16 [22.2] 13 [18.1] 0.533 
Atrioventricular block 36 [50.0] 39 [54.1] 0.615 
Atrioventricular block + LVSD 2 [2.8] 2 [2.8] 1.000 
LVSD and LBBB 18 [25.0] 18 [25.0] 1.000 
Abbreviations:  LVSD, left ventricular systolic dysfunction; TIA, transient ischaemic attack; ACE-i, 
angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; LBBB, left bundle 
branch block. 
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2.4.3 Subclinical atrial fibrillation 
During the study period, subclinical AF was detected in 18 South Asian and 36 
Caucasian subjects. The cumulative incidence of subclinical AF was significantly 
lower in South Asians (log rank p=0.002, figure 8) with an annual event rate of 6.9% 
compared with 13.9% in Caucasians. Table 6 summarises the multivariable 
regression analysis. Diabetes mellitus was an independent predictor of subclinical 
AF (odds ratio [OR] 2.64; 95% confidence interval [CI] 1.10-6.36) whilst South Asian 
ethnicity was independently associated with a lower rate of the arrhythmia (OR 0.39; 
95% CI 0.17-0.87). Age, gender, hypertension and ischaemic heart disease did not 
predict subclinical AF in this study population. 
 
Figure 8. Cumulative incidence of subclinical atrial fibrillation in South Asian and 
Caucasian patients with pacemakers 
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Table 6.   Multivariable regression analysis for the presence of subclinical atrial 
fibrillation 
Variable OR (95% CI) p-value 
Age 0.990 (0.957-1.024) 0.564 
Female gender 1.048 (0.491-2.237) 0.904 
South Asian 0.386 (0.171-0.869) 0.022 
Hypertension 0.930 (0.425-2.039) 0.857 
Diabetes mellitus 2.639 (1.096-6.355) 0.030 
Ischaemic heart disease 2.146 (0.935-4.927) 0.072 
 
2.4.4 Long-term clinical outcomes 
Table 7 demonstrates clinical outcomes in the presence and absence of AHREs. 
Clinical AF was only diagnosed in subjects who had evidence of AHREs. This 
occurred at an annual incidence of 10.2% in South Asians, a rate which was similar 
to that seen within Caucasian subjects (10.3%, p=0.840). The presence of AHREs 
did not significantly affect the incidence of cerebrovascular events or all-cause 
mortality in South Asians or Caucasians. 
Table 7. Long-term clinical outcomes of South Asian and Caucasian patients in the 
presence and absence of atrial high rate episodes 
South Asian ethnicity 
 AHREs present (n=18) 
AHREs absent 
(n=54) p-value 
Outcome Events % /year Events % /year   
Clinical AF 6 10.21 0 0 <0.001 
Stroke/TIA 2 3.40 8 4.00 0.694 
Death 11 18.72 22 10.99 0.133 
 
Caucasian ethnicity 
 AHREs present (n=36) 
AHREs absent 
(n=36) p-value 
Outcome Events % /year Events % /year   
Clinical AF 13 10.32 0 0 <0.001 
Stroke/TIA 3 2.26 2 1.59 0.643 
Death 8 6.35 7 5.27 0.772 
Abbreviations: AHREs, atrial high rate episodes; AF, atrial fibrillation; TIA, transient ischaemic 
attack. 
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2.5 Discussion 
To the best of the researcher’s knowledge, this is the first study to demonstrate a 
significantly lower incidence of device-detected subclinical AF in South Asians 
compared with Caucasians. This is despite South Asians having a higher 
prevalence of risk factors for the condition such as hypertension, ischaemic heart 
disease and diabetes mellitus, a condition which was also shown to be an 
independent predictor of subclinical AF. Furthermore, these results indicate that 
South Asian ethnicity is independently predictive of a lower incidence of subclinical 
AF. 
The findings of this study are consistent with previous studies which have shown a 
lower prevalence of clinical AF in South Asians9, 10, 13. However, these studies 
involved the screening of hospital or general practice records either to identify a 
clinical diagnosis of AF or to analyse electrocardiograms demonstrating AF; they did 
not involve long-term cardiac rhythm monitoring. As a consequence, it had 
previously been postulated that the lower prevalence of AF seen within South 
Asians was due to under-detection of the arrhythmia either because of a lower 
engagement of the population with medical services or because they experienced 
higher rates of paroxysmal AF which, by its nature, is more challenging to detect269. 
The results indicate that both of these scenarios are unlikely and support the 
observation that South Asians have a lower prevalence of AF. 
It is currently unclear why the incidence of AF is lower in South Asians. 
Echocardiographic studies have indicated that this ethnic group have smaller left 
atrial volumes when compared with Caucasians223, 224. Therefore, it is possible that 
South Asians have variations in left atrial structure which reduce the risk of 
developing atrial arrhythmia. Interestingly, no difference in left atrial size was seen 
in this study. The reason for this is uncertain but may relate to the fact that the 
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population in this study had a mean age of 74 years and so any previous difference 
in atrial size had slowly diminished over time due to the higher prevalence of risk 
factors known to increase atrial size such as hypertension, diabetes mellitus and 
coronary artery disease. Alternatively, the echocardiograms that were performed 
assessed left atrial diameter only and so did not necessarily accurately reflect 
differences in left atrial volumes. 
There is limited evidence that South Asians have differences in autonomic function 
with less vagal contribution compared with Caucasians234 and it is well recognised 
that the autonomic nervous system plays a crucial role in the development and 
maintenance of AF. Consequently, an alternative hypothesis is that the reduced 
incidence of AF in South Asians is related to variations in autonomic function. 
Finally it is possible that South Asians have differences in atrial electrophysiology 
which protect against the development of AF. Further research is required to 
explore these areas further. 
Within the study population, clinical AF exclusively occurred in patients with AHREs 
at an annual rate of around 10%. This is consistent with the findings of previous 
cardiac device studies265, 266. Although a logical finding, it highlights the importance 
of recognising AHREs as potential precursors to the development of clinical AF and 
as an indication to assess a patient’s potential stroke risk.  
There was no significant difference in the risk of stroke or all-cause mortality in 
patients who have evidence of AHREs although there was a trend towards a higher 
mortality rate in South Asians with AHREs. The findings of this study are in contrast 
to previous studies which found an association between the detection of AHREs 
and a significantly increased risk of thromboembolic events and cardiovascular 
mortality265, 266. It is likely therefore that the sample size and number of endpoints 
were not large enough to detect any underlying differences in these outcomes. 
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Finally, CIED implantation rates appeared to be lower in South Asians. South 
Asians constitute around 6% of the local population and yet only 3% of CIEDs were 
implanted in this ethnic group. A similar finding was recently demonstrated in an 
observational study of South Asians living in Leicestershire, England233. This raises 
the possibility that as well as a lower prevalence of AF, South Asians may also be 
less susceptible to bradyarrhythmias. The mechanisms underlying the differences in 
arrhythmia burden remain to be determined but may relate to variations in South 
Asian cardiac electrophysiology or the South Asian genome, areas which should be 
the focus of future research. 
2.5.1 Limitations 
Firstly, this is a retrospective cohort study and so exposes it to selection and recall 
bias. Although selection bias was possible, it was minimised through the recruitment 
of consecutive South Asian patients who met the eligibility criteria and the selection 
of the Caucasian controls was performed prior to screening of their medical records 
or any assessment of the incidence of atrial arrhythmia. Recall bias was minimised 
through the comprehensive assessment of the subjects’ medical records. Secondly, 
only patients with CIEDs were included in the analysis and so the results may not 
be generalizable to the whole South Asian population. However, the results are 
supported by and consistent with the findings of previous population-based studies. 
Thirdly, the researcher was not able to view every atrial electrogram demonstrating 
an AHRE due to the limitations of device storage capacity. As a consequence, the 
researcher only recorded AHREs that had been measured using device diagnostics 
and algorithms. The accuracy of these algorithms has previously been validated270 
and therefore, the researcher do not believe that false positive or false negative 
detections will have significantly influenced the results. Finally, due to the settings 
on some CIEDs, although the researcher was able to record whether an AHRE 
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lasted six minutes or not, the researcher was not able to accurately record the total 
length of subclinical AF in every patient. This prevented analysis on whether there 
was a difference in the overall burden of subclinical AF between ethnic groups. 
2.6 Conclusion 
In patients with a CIED, the incidence of subclinical AF is significantly lower in South 
Asians compared with Caucasians despite South Asians having a higher prevalence 
of hypertension, diabetes mellitus and ischaemic heart disease. Moreover, it is 
South Asian ethnicity itself which is an independent predictor of a lower incidence of 
subclinical AF. 
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Chapter 3. Left atrial size and function in a 
South Asian population and their potential 
influence on the risk of atrial fibrillation 
3.1 Abstract 
Background  South Asians have a low prevalence of atrial fibrillation (AF) 
compared with Caucasians despite having a higher prevalence of conventional risk 
factors for the arrhythmia. The reason for this disparity is uncertain but may be due 
to ethnic differences in atrial morphology. This study examines the association 
between ethnicity and left atrial (LA) size and function in South Asian and 
Caucasian subjects using the reference technique of cardiovascular magnetic 
resonance imaging (MRI). 
Methods   Retrospective case-control study of 60 South Asian and 60 Caucasian 
patients who had undergone a clinically-indicated MRI between April 2010 and 
October 2017 and had been found to have a structurally normal heart. LA and left 
ventricular (LV) volume and function were assessed and compared between the 
ethnicities. 
Results   In comparison with Caucasians, South Asians had significantly lower 
minimum (27.7±11.1 ml vs 34.9±12.3 ml, p=0.002) and maximum LA volumes 
(64.7±21.1 ml vs 80.9±22.5 ml, p<0.001), lower LV end-diastolic volume (p<0.001), 
lower LV stroke volume (p<0.001) and lower LV mass (p=0.022) and these values 
remained significant after correcting for body surface area. Further analysis 
revealed that LA volume was independently associated with South Asian ethnicity. 
There was no difference in LA function between the ethnic groups. 
-58- 
 
Conclusions   South Asians have reduced LA volumes and a proportionally smaller 
heart size in comparison to Caucasians. Smaller LA size may protect against the 
development of AF by reducing the risk of re-entrant circuit formation and atrial 
fibrosis development.  
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3.2 Introduction 
Structural remodelling of the atria plays a significant role in the development and 
maintenance of AF. It is therefore possible that the atrial structure in South Asians is 
morphologically different to Caucasian atria and that these variations confer 
protection against the development of AF.  
Studies have previously demonstrated that the risk of developing AF increases with 
increasing left atrial (LA) size38-40, 271. There is also evidence that lower passive and 
total LA emptying fractions (LAEFs) measured by cardiovascular magnetic 
resonance imaging (MRI) are independently associated with the development of 
AF271, 272.  
Although echocardiographic studies have previously suggested that South Asian 
atria may be proportionally smaller to Caucasian atria223, 224, the atrial size and 
function of South Asians has not been formally assessed using the reference 
technique of cardiovascular MRI. 
Therefore, the aim of this study was to use MRI to investigate atrial morphology and 
function in a retrospectively selected cohort of South Asian and Caucasian patients.  
The hypothesis was that South Asians have smaller LA size and therefore 
increased LA function. Any variations in LA size in South Asian patients may help 
improve our understanding of the low prevalence of AF in this ethnic group. 
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3.3 Methods 
3.3.1 Study population 
This was a single centre case-control study involving 60 patients of South Asian 
origin and 60 Caucasian controls matched for age and sex (figure 9). Patients were 
identified retrospectively from the local MRI database at Leeds Teaching Hospitals 
NHS Trust. All patients who had undergone a clinically indicated MRI scan for 
suspected cardiomyopathy between April 2010 and October 2017 were eligible for 
inclusion if their MRI scan had shown a structurally normal heart (based upon 
previously published normal values273) with no evidence of cardiomyopathy and 
patients had been discharged from further cardiology follow-up. 
 
Figure 9. Flow chart of ethnic distribution of cardiac MRI scans at the Yorkshire 
Heart Centre between 2010 - 2017 
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Prior to recruiting patients to the study, electronic hospital and GP patient records 
were screened for information regarding underlying co-morbidities. Subjects were 
excluded if they had evidence of ischaemic, valvular or structural heart disease, 
cerebrovascular disease, peripheral arterial disease, a history of cardiac arrhythmia 
or a confirmed inherited cardiac condition. 
The ethnicity of patients was populated using information from the NHS Patient 
Administration System. Patients were defined as South Asian if they had self-
reported their ethnicity as Indian, Pakistani, Bangladeshi, Sri Lankan, Nepalese or 
Bhutanese. Patients were defined as Caucasian if they had self-reported their 
ethnicity as White British. 
All participants had given written consent for their MRI images to be used for 
research purposes and the study was approved by the East Midlands - Derby 
Research Ethics Committee (REC reference 16/EM/0340). 
3.3.2 Image acquisition 
All MRI studies were performed using a 1.5 Tesla MR scanner (Intera or Ingenia 
CV, Philips Healthcare, Best, The Netherlands) and a vector ECG. Following 
acquisition of low resolution scout images, the main cardiac axes were planned 
using steady state free procession (SSFP) cine imaging. Long-axis steady SSFP 
cine images were obtained in 2-chamber and 4-chamber views. From these, a short 
axis stack covering the entire LV (thickness 10mm, gap 0mm) was planned and 
acquired. An axial stack of SSFP cine images was acquired covering the heart from 
the inferior cardiac aspect to the pulmonary artery bifurcation (slice thickness 6mm, 
no gap). Typical parameters for SSFP cine acquisitions were as follows: prospective 
gating, breath holding in end expiration, TR 2.6 ms, TE 1.3 ms, flip angle 40°, field 
of view 320 × 340 mm × 100 mm, voxel size 2 × 1.62 × 10 mm, 30 cardiac phases.   
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Ten minutes after administration of 0.2 mmol/kg Gadolinium DTPA contrast 
(Gadovist, Bayer AG, Zurich, Switzerland), late gadolinium enhancement (LGE) 
imaging was then performed. A stack covering the LV in 10-12 short axis slices 
(10mm thickness, 0mm gap) as well as 2-chamber view and 4-chamber views were 
obtained using an inversion recovery-prepared T1 weighted echo pulse sequence. 
The optimal inversion time (TI) to null normal myocardial signal was ascertained by 
the Look Locker approach. 
3.3.3 Image analysis 
Using the same software (CVI 42, Circle Cardiovascular Imaging, Calgary, Canada), 
post-processing analysis was performed by myself (1 years’ cardiac MRI 
experience) and reviewed by a consultant cardiologist with 7 years’ experience. LV 
volume and mass were manually calculated by contouring the endocardial and 
epicardial borders at end-diastole and end-systole of the LV short axis SSFP cine 
stack. LV papillary muscles were considered part of the LV cavity. 
Maximum, minimum and pre-atrial contraction LA volumes were assessed by 
manually tracing the LA endocardial border in the axial SSFP cine stack (figure 10). 
The atrial appendage was included in the analysis but the pulmonary veins were 
excluded. LA volume was calculated using the disk summation method273.  
Maximum LA Volume (LAVmax) was defined as the volume at end-systole before 
mitral valve opening. Minimum LA volume (LAVmin) was defined as the volume at 
end-diastole, immediately after mitral valve closure. Pre-atrial contraction LA volume 
(LAVPreA) was defined as the volume immediately before atrial contraction. 
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Figure 10. Manual tracing of LA endocardial border in axial stack. 
A. Minimum LA volume;  B. Maximum LA volume;  C. Pre-atrial contraction LA volume. 
 
Using these LA volume measurements, LA function was calculated as follows: 
• Total LA emptying fraction (LAEF): (LAVmax–LAVmin)/LAVmax 
• Passive LAEF: (LAVmax – LAVpre-a)/LAVmax  
• Active LAEF:(LAVpre-a – LAVmin)/LAVpre-a 
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All values were then indexed for body surface area (BSA) using the Mosteller 
method274 : 
 
3.3.4 Statistical analysis 
Statistical analysis was performed using SPSS (IBM SPSS Statistics Version 22.0, 
IBM Corporation, Armonk, New York). Normality of data was tested using a Shapiro-
Wilk test. Continuous variables were expressed as mean ± SD if normally 
distributed or median (interquartile range [IQR]) if non-normally distributed. 
Depending upon normality, a Student t test or Mann Whitney U test was used to 
compare continuous variables. Categorical variables were expressed as 
percentages and compared using Pearson’s chi-square test.  
For the regression model, the following independent variables were used. Age224, 275, 
276, male gender224, 276, BMI267 and the presence of hypertension277-279 or diabetes280, 
281 were chosen due to their relationship with LA volume. Ethnicity was included to 
determine its relationship with LA size and function. LV function, which is closely 
associated with LA volume282-287, was represented by LV ejection fraction (LVEF) 
and LV mass as measures of LV systolic and diastolic function respectively. 
Multivariable linear regression was used for variables with a statistical significance 
of <0.1 on univariable linear regression. P Values of less than 0.05 were considered 
statistically significant. 
  
• BSA (m2) =   Height (cm) x Weight (kg) 
      3600 
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3.4 Results 
3.4.1 Baseline characteristics 
A total of 60 South Asian subjects and 60 Caucasian controls were studied. The 
baseline characteristics of the South Asian and Caucasian cohorts are presented in 
table 8. The age range of participants was 18 to 70. Of the 60 South Asian subjects, 
41 were Pakistani, 17 were Indian and 2 were Bangladeshi. South Asians were 
significantly smaller (p=0.001) with a lower body surface area (BSA, p=0.016). The 
two cohorts were otherwise well matched.  
3.4.2 Variations in cardiac structure and function 
A comparison of LA and LV morphology and function in South Asians and 
Caucasians is shown in table 9. LAVmin and LAVmax were 20.6% and 20.0% smaller 
in South Asians compared with Caucasians and this trend remained significant after 
correcting for BSA. Passive, active and total LA function were not significantly 
different between South Asians and Caucasians. There was no significant 
difference in LV function between the two cohorts. However, South Asians had 
lower absolute LV mass and LV end-diastolic volume (LV EDV) and these 
differences remained significant after correcting for BSA. LGE was absent in all 
subjects. 
3.4.3 Univariable and multivariable regression analysis 
Univariable and multivariable relationships of LAVmin, LAVmax and LA function are 
shown in table 10 and table 11. LAVmin and LAVmax corrected for BSA were 
positively associated with age, body mass index (BMI), BSA-corrected LV mass and 
a history of hypertension. South Asian ethnicity was also a univariable predictor of 
smaller LA volumes. However, on multivariable linear regression, only age, South 
Asian ethnicity and BSA-corrected LV mass were independent predictors of LAVmin 
and LAVmax. 
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Total LA function was negatively associated with age, BMI and LV mass corrected 
for BSA on univariable regression. Of these variables, age and LV mass/BSA had a 
significant association with reduced LA function on multivariable analysis. Passive 
and active LA function demonstrated similar results. 
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Table 8.   Baseline characteristics 
 South Asian Caucasian P-value 
N 60 60  
Age 35.0 (22) 34.0 (22) 0.902 
Male gender, n [%] 30 [50] 30 [50] 1.000 
Height, cm 165.3 ± 11.5 171.6 ± 9.3 0.001 
Weight, kg 72.5 ± 16.6 78.6 ± 17.3 0.052 
Body surface area, m2 1.82 1.93 0.016 
Body mass index, kg/m2 26.1 (6.0) 26.1 (6.5) 0.865 
BP- systolic, mmHg 123 (7) 121 (16) 0.117 
BP- diastolic, mmHg 74 (6) 73 (12) 0.123 
Heart rate, bpm 75.5 ± 16.9 71.6 ±15.6 0.068 
Diabetes, n [%] 5 [8.3] 1 [1.7] 0.094 
HbA1c, mmol/mol 60 ± 18.1 77 0.101 
HbA1c, % 7.6 ± 1.6 9.2 0.101 
Treated hypertension, n [%] 5 [8.3] 6 [10.0] 0.752 
Aspirin, n [%] 3 [5.0] 2 [3.3] 0.648 
Statin, n [%] 5 [8.3] 3 [5.0] 0.464 
ACE-inhibitor, n [%] 6 [10.0] 7 [11.7] 0.769 
Beta blocker, n [%] 2 [3.3] 4 [6.7] 0.402 
Calcium channel blocker, n [%] 4 [6.7] 4 [6.7] 1.000 
Diuretic, n [%] 1 [1.7] 2 [3.3] 0.559 
Abbreviations: BP, blood pressure; HbA1c, haemoglobin A1c; ACE, angiotensin-
converting enzyme. 
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Table 9.  Left atrial volume and function and left ventricular mass, volume and function 
 South Asian Caucasian P-value 
LAVmin , ml 27.7 ± 11.1 34.9 ± 12.3 0.002 
LAVmin/BSA, ml/m2 14.9 ± 5.1 18.1 ± 5.8 0.004 
LAVmax , ml 64.7 ± 21.1 80.9 ± 22.5 <0.001 
LAVmax/BSA, ml/m2 35.2 ± 9.1 41.9 ± 10.5 0.001 
Passive LAEF, % 34.1 ± 11.2 33.2 ± 10.4 0.567 
Active LAEF, % 35.4 ± 10.0 34.8 ± 10.2 0.720 
Total LAEF, % 57.8 ± 7.4 56.8 ± 7.9 0.603 
LV ejection fraction, % 60.0 (7.7) 62.0 (7.5) 0.147 
LV mass, g 83.9 ± 28.8 94.8 ± 24.6 0.022 
LV mass/BSA, g/m2 44.8 ± 10.4 49.0 ± 10.2 0.028 
LVEDV, ml 130.9 ± 33.4 159.7 ± 33.0 <0.001 
LVEDV/BSA, ml/m2 71.9 ± 14.4 82.8 ± 13.5 <0.001 
LVESV, ml 54.8 ± 24.3 60.4 ± 17.0 0.148 
LVESV/BSA, ml/m2 30.0 ± 12.0 31.3 ± 7.8 0.150 
LV SV, ml 76.9 ± 19.0 99.3 ± 20.3 <0.001 
LV SV/BSA, ml/m2 42.3 ± 8.0 51.5 ± 8.4 <0.001 
Abbreviations: LAVmin, minimum left atrial volume; BSA, body surface area; LAVmax, 
maximum left atrial volume; LAEF, left atrial ejection fraction; LV, left ventricle; LVEDV, 
left ventricular end-diastolic volume;  LVSDV, left ventricular end-systolic volume; LV 
SV, left ventricular stroke volume. 
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Table 10. Univariable and multivariable linear regression analysis for LAVmin/BSA, 
LAVmax/BSA 
LAVmin/BSA 
 Univariable model Multivariable model 
 Beta 
coefficient 
Standard 
error p value 
Beta 
coefficient 
Standard 
error 
p 
value 
Age 0.457 1.327 <0.001 0.383 0.034 <0.001 
Male gender 0.153 1.029 0.094 -0.012 0.987 0.894 
South Asian -0.274 1.001 0.001 -0.201 0.837 0.008 
Body mass index 0.259 0.098 0.004 0.104 0.086 0.183 
LV ejection 
fraction 0.108 0.043 0.239    
LV mass/BSA 0.403 0.046 <0.001 0.357 0.048 <0.001 
Hypertension 0.229 1.756 0.012 0.083 1.518 0.286 
Diabetes mellitus 0.014 2.388 0.882    
LAVmax/BSA  
Age 0.356 0.064 <0.001 0.291 0.066 0.001 
Male gender 0.112 1.882 0.221    
South Asian -0.325 1.792 <0.001 -0.267 1.625 0.001 
Body mass index 0.206 0.181 0.024 0.083 0.166 0.317 
LV ejection 
fraction 0.093 0.079 0.312    
LV mass/BSA 0.339 0.085 <0.001 0.277 0.078 0.001 
Hypertension 0.203 3.214 0.026 0.089 2.970 0.288 
Diabetes mellitus 0.000 4.346 0.999    
Abbreviations: LAVmin, minimum left atrial volume; LAVmax, maximum left atrial 
volume; LV, left ventricular; BSA, body surface area. 
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Table 11. Univariable and multivariable linear regression analysis for passive, 
active and total LA EF 
Passive LA EF 
 Univariable model Multivariable model 
 Beta 
coefficient 
Standard 
error 
p 
value 
Beta 
coefficient 
Standard 
error 
p 
value 
Age -0.529 0.001 <0.001 -0.491 0.001 <0.001 
Male gender -0.021 0.020 0.819    
South Asian 0.040 0.020 0.665    
Body mass 
index -0.260 0.002 0.004 -0.081 0.002 0.330 
LV ejection 
fraction -0.113 0.001 0.221    
LV mass/BSA -0.081 0.001 0.382    
Hypertension -0.175 0.034 0.056 0.034 0.032 0.286 
Diabetes 
mellitus -0.219 0.044 0.016 -0.133 0.039 0.098 
Active LA EF  
Age 0.218 0.001 0.017 0.193 0.001 0.031 
Male gender -0.097 0.018 0.290    
South Asian 0.033 0.018 0.720    
Body mass 
index 0.059 0.002 0.520    
LV ejection 
fraction 0.028 0.001 0.761    
LV mass/BSA -0.202 0.001 0.027 -0.191 0.001 0.031 
Hypertension 0.039 0.032 0.676    
Diabetes 
mellitus 0.220 0.041 0.016 0.168 0.041 0.062 
Total LA EF 
Age -0.304 0.000 0.001 -0.272 0.000 0.003 
Male gender -0.125 0.014 0.174    
South Asian 0.068 0.014 0.458    
Body mass index -0.180 0.001 0.049 -0.077 0.001 0.397 
LV ejection 
fraction -0.084 0.001 0.360    
LV mass/BSA -0.258 0.001 0.004 -0.248 0.001 0.004 
Hypertension -0.119 0.024 0.196    
Diabetes mellitus -0.012 0.032 0.893    
Abbreviations: LA EF, left atrial ejection fraction; LV, left ventricular; BSA, body 
surface area. 
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3.5 Discussion 
To the best of the researcher’s knowledge, this is first study to compare LA volume 
and function between South Asians and Caucasians using the reference technique 
of cardiovascular MRI. The researcher has demonstrated that South Asians have 
significantly reduced minimum and maximum LA volumes compared with 
Caucasians, even after correction for BSA. This is despite the fact that South Asians 
have a higher prevalence of risk factors for LA enlargement such as hypertension9, 
10, diabetes mellitus9, 10 and obesity206. This study also shows that South Asians 
have lower LV mass, smaller LV EDV and lower LV stroke volume compared with 
Caucasians. In combination with the reduced LA volume, this would indicate that the 
South Asian heart is proportionally smaller than the Caucasian heart. 
On multivariable linear regression, South Asian ethnicity remains an independent 
predictor of reduced LA size, even when measures of body size are included, and 
indicates that South Asian ethnicity plays a significant role in the morphology of the 
left atrium. Age and LV mass/BSA (a measure of diastolic function) are also 
independently associated with LA volume. These results support the findings of 
previous echocardiographic studies which demonstrated higher LA volume indexed 
for BSA (LAVi) in healthy subjects ≥50 years as compared with those <50 years of 
age (33.4±12.5 vs. 29.1±13.5, p< 0.001) and in normal LV geometry compared with 
LVH (23±5.1 vs. 26.2±7.3, p<0.001)276, 285. 
No difference in LA function was seen between South Asians and Caucasians 
although this is not entirely unexpected. Whilst LA dysfunction has been shown to 
be independently associated with the development of AF, in the absence of any 
known cardiac pathology, a reduction in LA function would be unusual, particularly 
in cohorts who are well matched in terms of baseline characteristics. Age was 
shown to be an independent predictor of a change in LA function, an expected 
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finding which is consistent with other studies276, 288. LV mass/BSA was also 
identified as being independently associated with LA function. This is likely to reflect 
the changes in diastolic function which occur with increasing LV mass289 and lead to 
a reduction in LA function290. 
3.5.1 Comparison with other imaging studies 
Echocardiographic studies have previously been performed to compare cardiac 
chamber sizes in different ethnic groups. Chahal et al found that South Asians had 
smaller LA volumes compared with Caucasians (25.0±7.7 ml vs. 30.8±10.4 ml), 
even after indexing for BSA (14.2±4.0 ml/m2 vs. 16.3±4.8 ml/m2)223 whilst the 
EchoNoRMAL study showed that LA diameter, LV size and LV volume were lowest 
in the South Asian ethnic group224. The results of this study, using MRI, support 
these findings. However, volumetric analysis by MRI is superior to 
echocardiography291, 292 and it is likely that these results will have greater 
reproducibility in future studies. 
3.5.2 South Asian ethnicity and its relationship with body 
size 
This study indicates that South Asians have a smaller heart size, shorter height and 
lower body surface area compared with Caucasian counterparts. These findings are 
consistent with those of other studies which show that South Asians are consistently 
of a smaller body size206, 225, 230. The study population was derived from the same 
geographical area where they are likely to be subjected to similar socioeconomic 
conditions and exposed to the same environmental factors known to influence 
growth, namely disease, nutrition and access to healthcare293.  Therefore, although 
the reason for this disparity in body size is not certain, it is more likely to be related 
to a genetic rather than environmental cause. There is evidence to support this from 
a study by Wilde et al comparing South Asian children living in the Netherlands with 
South Asian children living in India230. They found similar growth trajectories in both 
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groups, suggesting that genetic influences play a more important role than 
environmental factors. 
3.5.3 South Asian atrial size and the risk of atrial fibrillation 
South Asians have a lower prevalence of AF compared with Caucasians and this 
may be related to their smaller LA size. It is well established that increasing LA size 
is an important independent predictor of AF40. This observation is likely to be related 
to the fact that increasing atrial size can provide favourable substrate for the 
development of AF through increased local intra-atrial conduction block and the 
creation of multiple re-entrant circuits42, 294. There is also an increased risk of 
developing atrial fibrosis with atrial enlargement due to inflammation, oxidative 
stress and the expression of pro-fibrotic factors (transforming growth factor beta-1 
and angiotensin-II) which can subsequently alter atrial conduction and atrial ERPs36. 
The combination of these changes favours the development of re-entry and 
therefore the occurrence of AF. 
It seems reasonable to conclude therefore that since South Asians have smaller 
atria compared to Caucasians, their LA volume is required to increase to a much 
larger size proportionally before AF can develop and become sustained. As a result 
of this, the rate of AF amongst South Asians is significantly lower. 
3.5.4 Limitations 
Firstly, the study population was taken from individuals attending for clinical cardiac 
MRI scans. Although there was no evidence of cardiovascular disease, it is possible 
that they may have had occult conditions that were not apparent. However, the 
researcher rigorously screened patient records and excluded anyone who was 
subsequently found to have cardiac pathology. Secondly, the retrospective design 
of this study is associated with selection bias, which was minimised by recruiting 
consecutive patients who met the eligibility criteria, and recall bias which was 
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minimised through the assessment of subjects’ hospital records and the contacting 
of their general practitioners for any missing information. 
 
3.6 Conclusion 
This is the first study which demonstrates that South Asians have smaller LA 
volumes compared with Caucasians, even when matching for BSA, using the 
reference technique of MRI to measure cardiac dimensions. South Asians also have 
reduced LV EDV and smaller LV mass indicating that the South Asian heart is 
proportionally smaller to the Caucasian heart and this is likely to be due to genetic 
factors. Reduced LA volume may confer a degree of protection against the 
development of re-entrant circuits and fibrosis within the atria and may explain why 
South Asians have a reduced prevalence of AF. 
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Chapter 4. Electrophysiological properties of 
the South Asian heart 
4.1 Abstract 
Objective:   The South Asian population has a lower burden of arrhythmia 
compared with Caucasians despite a higher prevalence of traditional cardiovascular 
risk factors. The researcher aimed to determine whether this was due to differences 
in the electrophysiological properties of the South Asian heart. 
Methods:   A retrospective cohort study of South Asian and Caucasian patients 
who underwent an electrophysiology study for supraventricular tachycardia (SVT) 
between 2005 and 2017 was performed. Surface electrocardiogram, intracardiac 
electrogram and intracardiac conduction intervals were measured and a comparison 
between the two ethnic cohorts was performed. 
Results:   A total of 5,908 patients underwent an electrophysiology study at the 
Yorkshire Heart Centre, UK, during the study period. Of these 262 were South 
Asian and 113 met the eligibility criteria. South Asians had a significantly higher 
resting heart rate (p= 0.024), shorter QRS duration (p= 0.012) and a shorter 
atrioventricular (AV; p= 0.001)) and ventriculoatrial (VA; p= 0.013) effective 
refractory period (ERP). There was no difference in atrial or ventricular ERP. On 
linear regression analysis, South Asian ethnicity was independently predictive of a 
higher resting heart rate, narrower QRS and shorter AV-ERP and VA-ERP. 
Conclusions:   South Asians have significant differences in their resting heart rate, 
QRS duration and AV nodal function compared with Caucasians. These differences 
may reflect variations in autonomic function and may also be influenced by genetic 
-76- 
 
factors. Electrophysiological differences such as these may help to explain why 
South Asians have a lower burden of arrhythmia. 
4.2 Introduction 
South Asians appears to have a significantly different burden of arrhythmia in 
comparison with Caucasians. The prevalence of AF is lower but there is also 
evidence to suggest that South Asians are at less risk of bradyarrhythmia233 whilst 
being at more risk of ventricular arrhythmia213.  
The mechanisms underlying this altered susceptibility to arrhythmia remains unclear 
but it raises the possibility of a difference in the cardiac electrophysiology of South 
Asian hearts, an area which has not previously been investigated.  
Therefore to improve our understanding of South Asian cardiac electrophysiology, 
the aim of this study was to investigate baseline electrocardiographic and 
intracardiac conduction intervals in a retrospectively selected cohort of South Asian 
and Caucasian patients undergoing invasive electrophysiology studies. The 
researcher hypothesized that South Asians would have differences in cardiac 
conduction compared with Caucasians.  
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4.3 Methods 
4.3.1 Study population 
A single centre retrospective cohort study was performed on patients undergoing 
electrophysiology studies for supraventricular tachycardia (SVT) at the Yorkshire 
Heart Centre, Leeds Teaching Hospitals NHS Trust, between 1st January 2005 and 
31st December 2017. Patients were identified from the local cardiac 
electrophysiology database and all South Asian patients were considered for 
enrolment into the study. Patients were excluded if they were under the age of 16 
years, underwent ablation for atrial fibrillation, atrial flutter or ventricular tachycardia 
or had a history of congenital or structural heart disease. Caucasian controls 
matched for age and sex, who also had a diagnosis of SVT, were identified from the 
same local cardiac electrophysiology database. 
Ethnicity was identified using data from the NHS Patient Administration System. 
Patients were defined as South Asian if they had self-reported their ethnicity as 
Indian, Pakistani, Bangladeshi, Sri Lankan or Nepalese. Patients were defined as 
Caucasian if they had self-reported their ethnicity as White British. 
4.3.2 Electrophysiology study 
All patients underwent electrophysiology study in a fasted state. Antiarrhythmic or 
rate-limiting medications were discontinued for at least five half-lives prior to the 
procedure. Procedures were either performed under general anaesthetic or under 
local anaesthetic with the option of sedation. Three or four diagnostic 
electrophysiology catheters were introduced into the right and/or left femoral veins. 
Quadripolar or octapolar catheters were positioned at the His bundle and right 
ventricular apex. A decapolar catheter was positioned in the coronary sinus. At the 
operator’s discretion, a quadripolar catheter was also positioned in the high right 
atrium. Surface and intracardiac electrocardiograms were continuously recorded 
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and stored using the CardioLab Electrophysiology recording system (General 
Electric Medical Systems, Milwaukee, Wisconsin, USA). Programmed right 
ventricular stimulation was performed with a single extrastimulus at a cycle length of 
600 milliseconds (ms) until either ventricular or ventriculoatrial (VA) ERP was 
reached. Programmed atrial stimulation was performed with a single extrastimulus 
at a cycle length of 600ms until either atrial ERP or atrioventricular (AV) ERP was 
reached. Incremental atrial pacing was performed until atrioventricular block 
occurred in order to record atrioventricular Wenkebach (AVW) cycle length. In 
patients with atrioventricular nodal re-entrant tachycardia or a concealed accessory 
pathway, measurements were taken at the start of the study, prior to the 
administration of isoprenaline. In patients with a manifest accessory pathway, 
measurements were taken following ablation, after the administration of 
isoprenaline, and once the heart rate had returned to baseline. 
4.3.3 Data collection 
The conduction intervals of each electrophysiology study were measured using 
CardioLab analysis software (General Electric Medical Systems, Milwaukee, 
Wisconsin, USA). Heart rate, P-wave duration, and the RR, PR, QRS, QT and QTC 
intervals were all measured on the surface electrocardiogram (Figure 11). The AA 
interval (sinus cycle length), PA interval, AH interval (AV node conduction time) and 
HV interval (His-purkinje conduction) and the atrial ERP, atrioventricular ERP, 
atrioventricular Wenkebach cycle length, ventriculoatrial ERP and ventricular ERP 
were all measured using the intracardiac electrogram (Figure 11, Figure 12, Figure 
13, Figure 14). The intervals were measured using electronic calipers at a sweep 
speed of 200 millimetres/second. All surface electrocardiogram intervals were 
measured in lead II. The definition of each conduction interval is found in table 12. 
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Table 12. Definitions of conduction intervals measured on the surface and 
intracardiac electrocardiograms 
Surface electrocardiogram 
P wave duration Time interval between the onset and offset of the P wave 
RR The time interval between two successive R-waves of the QRS 
complex 
PR Time interval between the onset of the P wave and the onset of the 
QRS complex 
QRS Time interval between the onset of the Q wave and the offset of the 
S wave 
QT Time interval between the onset of the QRS complex and the offset 
of the T wave 
QTc QT interval corrected for heart rate 
Intracardiac electrogram 
AA The time interval between two successive A waves 
PA The time interval between the onset of the P wave on the surface 
ECG and the rapid deflection of the A wave on the HIS channel. 
AH Time interval between the rapid deflection of the A wave to the onset 
of the H deflection using the HIS channel. 
HV Time interval between the onset of the H deflection to the earliest 
onset of ventricular activation in either the intracardiac or surface 
ECG. 
Atrial ERP Maximum S1-S2 coupling interval which fails to produce an A wave 
Atrioventricular 
ERP 
Maximum S1-S2 coupling interval which fails to produce a HIS 
potential 
Ventricular ERP Maximum S1-S2 coupling interval which fails to produce a V wave 
Venriculoatrial 
ERP 
Maximum S1-S2 coupling interval which fails to produce a HIS 
potential 
AVW Maximum S1-S1 interval which fails to produce a V wave during 
incremental atrial pacing 
Abbreviations: ERP, effective refractory period; AVW, atrioventricular wenckebach. 
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Figure 11. Surface and intracardiac electrocardiogram measurements 
A. P wave duration (108ms), PR (189ms), QRS (84ms) and QT (418ms) intervals. 
B. PA (37ms), AH (80ms) and HV (47ms) intervals. 
  
A. 
B. 
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Figure 12. Measurement of effective refractory period (ERP). 
A. Measurement of atrioventricular ERP. 
B. Measurement of atrial ERP. 
A. 
B. 
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Figure 13.  Measurement of effective refractory period (ERP). 
A. Measurement of ventriculoatrial ERP. 
B. Measurement of ventricular ERP. 
A. 
B. 
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Figure 14.   Measurement of atrioventricular Wenckebach. 
 
Electronic patient records were examined and information on patients’ co-
morbidities, medication history, length of cardiology follow-up following the 
electrophysiology study and evidence of SVT recurrence was recorded. The study 
was reviewed by the Research and Innovation Department at Leeds Teaching 
Hospitals NHS Trust and approved as a Service Evaluation Project. 
4.3.4 Statistical analysis 
Statistical analysis was performed using SPSS (IBM SPSS Statistics Version 22.0, 
IBM Corporation, Armonk, New York). Normality of data was tested using a Shapiro-
Wilk test. Continuous variables were expressed as mean ± SD if normally 
distributed or median (interquartile range [IQR]) if non-normally distributed. Student t 
test or Mann Whitney U test were used to compare continuous variables depending 
on normality. Categorical variables were expressed as percentages and compared 
using Pearson’s chi-square test. P values of less than 0.05 were considered 
statistically significant. 
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Linear regression analysis was used to further evaluate the relationship between 
ethnicity and any statistically significant electrophysiological intervals with 
adjustment for age, gender, left atrial diameter, hypertension and diabetes mellitus. 
Univariable linear regression was initially performed and any variable with a 
statistical significance of <0.1 was included in the multivariable regression model. 
 
4.4 Results 
4.4.1 Study cohort 
During the study period, a total of 5,908 electrophysiology studies were performed 
at the Yorkshire Heart Centre with 5,583 procedures performed in Caucasians and 
262 procedures performed in South Asians. The total referral population includes 
1,814,206 Caucasians and 264,438 South Asians. Therefore, electrophysiological 
studies were performed in 0.31% of the Caucasian population and 0.09% of the 
South Asian population. A summary of the indications for the electrophysiology 
studies in each cohort is found in table 13. 
Table 13.  Summary of the indications for electrophysiology studies 
in all Caucasians and South Asians 
 Caucasian 
(n= 5,583) 
South Asian 
(n= 262) 
Atrial fibrillation 1713 (30.7%) 20 (7.6%) 
Atrial flutter 1052 (18.8%) 21 (8.1%) 
Atrial tachycardia 202 (3.6%) 6 (2.3%) 
SVT 1413 (25.3%) 135 (51.5%) 
WPW 563 (10.1%) 49 (18.7%) 
Ventricular arrhythmia 640 (11.5%) 31 (11.8%) 
Abbreviations: SVT, supraventricular tachycardia; WPW, Wolff-Parkinson-White 
syndrome 
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A final South Asian cohort of 113 subjects was identified and matched with 
Caucasian controls after 149 patients failed to meet the eligibility criteria (figure 15). 
 
Figure 15. Flow chart of ethnic distribution of electrophysiology studies at the 
Yorkshire Heart Centre between 2005 – 2017. 
 
4.4.2 Baseline characteristics 
The characteristics of the study participants are summarised in table 14. The two 
cohorts were well matched with no significant difference in co-morbidities, 
medication, length of follow up or the recurrence of arrhythmia. There was a non-
significant trend towards a higher prevalence of diabetes mellitus and ischaemic 
heart disease amongst South Asians. 
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4.4.3 Surface electrocardiogram intervals 
Resting heart rate was significantly higher (p= 0.024) and QRS duration was 
significantly shorter (p= 0.012) in South Asians as shown in table 15. There was no 
significant difference in the P wave duration or PR interval between the ethnicities 
and once corrected for heart rate, there was no difference in the QT interval. 
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Table 14.  Baseline characteristics 
 South Asian Caucasian P-value 
N 113 113 * 
Age 41.3±13.6 41.3±13.6 0.981 
Male gender, n [%] 39 [34.5] 39 [34.5] 1.000 
Height, centimetres 163.8±7.9 169.8±10.4 0.023 
Weight,  kilograms 76.5±18.1 76.1±20.4 0.592 
Left atrial diameter, millimetres 34.0±5.9 33.7±3.9 0.840 
Hypertension, n [%] 13 [11.5] 10 [8.8] 0.509 
Diabetes mellitus, n [%] 12 [10.6] 6 [5.3] 0.140 
Previous stroke/TIA, n [%] 1 [0.9] 2 [1.8] 0.561 
Venous thromboembolism, n [%] 0 [0.0] 1 [0.9] 0.316 
Ischaemic heart disease, n [%] 6 [5.3] 2 [1.8] 0.150 
Peripheral arterial disease, n [%] 0 [0.0] 0 [0.0] * 
CKD stage III-V, n[%] 2 [1.8] 1 [0.9] 0.561 
Diagnosis    
AVNRT, n[%] 78 [69.0] 81 [71.6] 0.662 
Accessory pathway, n[%] 15 [13.3] 9 [8.0] 0.195 
No inducible arrhythmia, n[%] 20 [17.7] 23 [20.4] 0.611 
Medication 
ACE-i/ARB, n [%] 15 [13.3] 9 [8.0] 0.195 
Beta-blocker, n [%] 52 [46.0] 39 [34.5] 0.078 
Calcium-channel blocker, n [%] 17 [15.0] 9 [8.0] 0.095 
Diuretic, n [%] 1 [0.9] 2 [1.8] 0.561 
Aldosterone antagonist, n [%] 0 [0.0] 0 [0.0] * 
Statin, n [%] 10 [8.8] 10 [8.8] 1.000 
Antiplatelet, n [%] 8 [7.1] 7 [6.2] 0.789 
Anticoagulation, n [%] 0 [0.0] 1 [0.9] 0.316 
Antiarrhythmic, n [%] 14 [12.4] 10 [8.8] 0.677 
Procedural anaesthesia 
General anaesthetic, n [%] 6 [5.3] 6 [5.3] 1.000 
Local anaesthetic + sedation, n [%] 73 [64.6] 71 [62.8] 0.771 
Local anaesthetic only, n [%] 34 [30.1] 36 [31.9] 0.771 
Follow-up 
Length of follow-up, days 107 (153) 103 (129) 0.929 
Recurrence of arrhythmia, n [%] 4 [3.5] 5 [4.4] 0.734 
Abbreviations: TIA, transient ischaemic attack; CKD, chronic kidney disease; AVNRT, 
atrioventricular nodal reentrant tachycardia; ACE-i, angiotensin-converting enzyme; ARB, 
angiotensin II receptor blocker. 
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Table 15.  Electrocardiographic and conduction intervals 
 South Asian Caucasian p-value 
Surface electrocardiogram intervals 
Heart rate, BPM 82.5 (18) 78.0 (18) 0.024 
P-wave duration, ms 107.0 (19) 105.0 (22) 0.221 
RR, ms 726.5 (171) 764.0 (177) 0.025 
PR, ms 155.9±20.7 158.7±22.6 0.351 
QRS, ms 92.0 (16) 96.0 (15) 0.012 
QT, ms 372.5 (43) 387.0 (36) 0.001 
QTc, ms 433.9 (53) 441.0 (42) 0.182 
Intracardiac electrogram intervals 
AA, ms 720.0 (180) 763.0 (161) 0.070 
PA, ms 44.0 (18) 41.0 (14) 0.169 
AH, ms 66.0 (23) 71.0 (26) 0.093 
HV, ms 37.0 (12) 37.5 (13) 0.841 
Intracardiac conduction intervals 
Atrial ERP, ms 250 (60) 240 (40) 0.332 
Total number of measurements* 66 54  
Atrioventricular ERP, ms 280 (50) 300 (60) 0.001 
Total number of measurements* 47 59  
AVW cycle length, ms 320 (58) 340 (68) 0.045 
Total number of measurements 113 113  
Ventriculoatrial ERP, ms 300 (60) 320 (93) 0.013 
Total number of measurements* 51 52  
Ventricular ERP, ms 240 (30) 240 (35) 0.172 
Total number of measurements* 62 61  
Abbreviations: BPM, beats per minute; ms, milliseconds; ERP, effective refractory period; 
AVW, atrioventricular wenckebach. 
* Measurements recorded at a cycle length of 600 ms. 
 
 
4.4.4 Intracardiac electrogram and conduction intervals 
South Asians had significantly shorter AV-ERP (p= 0.001) and VA-ERP (p= 0.013) 
intervals (table 15). The AVW cycle length (p= 0.045) was correspondingly shorter 
(table 15). There were no differences in atrial or ventricular ERP between the two 
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groups and no differences were seen in the intracardiac electrogram intervals (table 
15).  
4.4.5 Linear regression analysis 
On univariable analysis, South Asian ethnicity was associated with a higher heart 
rate, narrower QRS and lower AV- and VA-ERP (table 16). Male gender was 
associated with a lower heart rate and wider QRS whilst diabetes mellitus was 
predictive of a higher heart rate (table 16). No variable was found to be associated 
with AVW cycle length. On multivariable analysis, South Asian ethnicity and male 
gender remained independently predictive of heart rate, QRS duration and AV-ERP 
(table 16). 
 
  
-90- 
 
 
 
Table 16.  Univariable and multivariable linear regression analysis for predictors of 
heart rate, QRS, AV-ERP, VA-ERP and AVW 
 Univariable model Multivariable model 
 B (95% CI) p 
value 
B (95% CI) p 
value 
Heart rate 
Age 0.005 (-0.145 to 0.155) 0.950    
Male gender -6.800 (-10.985 to -2.615) 0.002 -6.687 (-10.815 to -2.559) 0.002 
SA ethnicity 4.354 (0.321 to 8.387) 0.034 4.049 (0.108 to 7.990) 0.044 
LA diameter -0.274 (1.353 to 0.805) 0.612    
Hypertension 5.312 (-1.375 to 11.999) 0.119    
Diabetes mellitus 8.254 (0.625 to 15.884) 0.034 7.220 (-0.240 to 14.680) 0.058 
QRS 
Age -0.075 (-0.200 to 0.050) 0.238    
Male gender 5.985 (2.498 to 9.472) 0.001 5.997 (2.539 to 9.456) 0.001 
SA ethnicity -3.597 (-6.967 to -0.227) 0.037 -3.616 (-6.908 to -0.324) 0.032 
LA diameter 0.198 (-0.496 to 0.893) 0.568    
Hypertension 0.065 (-5.552 to 5.681) 0.982    
Diabetes mellitus -3.033 (-9.459 to 3.393) 0.353    
AV-ERP 
Age -0.230 (-1.078 to 0.618) 0.591    
Male gender 17.082 (-4.951 to 39.115) 0.127    
SA ethnicity -36.158 (-56.976 to -15.340) 0.001 -96.721 (-169.363 to -24.079) 0.012 
LA diameter 8.147 (-0.961 to 17.256) 0.076 9.121 (1.379 to 16.864) 0.024 
Hypertension 0.407 (-35.559 to 36.373) 0.982    
Diabetes mellitus -19.342 (-58.518 to 19.834) 0.330    
VA-ERP 
Age    -0.475 (-1.751 to 0.800) 0.461 
Male gender    24.841 (-11.196 to 60.878) 0.174 
SA ethnicity    -47.894 (-82.973 to -12.814) 0.008 
LA diameter    -0.439 (-8.131 to 7.252) 0.905 
Hypertension    -34.946 (-110.857 to 40.964) 0.363 
Diabetes mellitus    -58.447 (-140.675 to 23.782) 0.162 
AVW 
Age -0.132 (-0.722 to 0.458) 0.660    
Male gender 13.971 (-2.845 to 30.787) 0.103    
SA ethnicity -13.803 (-29.840 to 2.234) 0.091 -12.820 (-28.809 to 3.168) 0.115 
LA diameter 2.629 (-1.166 to 6.424) 0.170    
Hypertension -25.985 (-52.659 to 0.690) 0.056 -24.560 (-51.204 to 2.083) 0.071 
Diabetes mellitus -22.831 (-53.756 to 8.094) 0.147    
Abbreviations: SA, South Asian; LA, Left atrial; AV-ERP, atrioventricular effective refractory period; 
AVW, atrioventricular wenckebach cycle length; VA-ERP, ventriculoatrial effective refractory period. 
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4.5 Discussion 
To the best of the researcher’s knowledge, this is the first study to compare the 
electrophysiological properties of South Asian and Caucasian hearts using invasive 
techniques. Within a diverse multi-ethnic population over a 13 year period, this 
study has found that electrophysiology studies were performed three times more 
often in Caucasians than in South Asians. It has shown a significant difference in 
heart rate, AV nodal function and QRS duration between South Asians and 
Caucasians but no difference in atrial ERP or P wave duration. 
4.5.1 Heart rate and AV nodal function 
The findings of this study indicate that South Asians have a higher resting heart 
rate, lower AV-ERP and lower VA-ERP compared with Caucasians and that these 
differences are independently associated with ethnicity. A plausible explanation for 
this is that South Asians may have differences in autonomic function. 
The autonomic nervous system (ANS) heavily influences cardiac conduction 
through a complex interaction between sympathetic and parasympathetic 
innervation and this effect is most apparent at the AV node and sinoatrial node. 
Sympathetic activity increases sinoatrial node automaticity and enhances AV nodal 
conduction with the overall effect of increasing heart rate whilst parasympathetic 
activity has the opposing effects48. There is limited evidence to suggest that South 
Asians have impaired autonomic function with less vagal contribution and increased 
sympathetic tone234. Higher sympathetic activity could explain the study’s findings of 
an increased heart rate and reduced AV nodal refractoriness in South Asians. 
Differences in autonomic function might also influence South Asians susceptibility to 
developing AF. It is now well recognised that the ANS plays an important role in the 
genesis of AF. The onset of paroxysmal AF is often preceded by an increase in 
parasympathetic activity, particularly in those without structural heart disease44. This 
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is likely to be due to the fact that vagal stimulation causes heterogeneous 
shortening of atrial APDs and ERPs creating an environment suitable for the 
development of atrial re-entrant circuits45-47. If South Asians do have increased 
sympathetic tone, this may play a role in preventing the development of AF. 
However, further research is required to confirm these findings. 
4.5.2 QRS duration 
My findings show that South Asians have a shorter QRS duration. Despite previous 
studies having demonstrated ethnic differences in QRS duration between black and 
white Americans295 and in a multi-ethnic Asian population296, the aetiology behind 
these differences has not been established.  
QRS duration has been shown to correlate with body size297 and South Asians are 
known to be of a smaller stature225 with smaller hearts224 compared with 
Caucasians. Therefore, in the South Asian cohort, it is possible that a shorter QRS 
duration simply relates to their smaller heart size. 
More interestingly, the difference in QRS duration could be related to genetic 
variation. The QRS complex represents ventricular depolarisation and conduction 
time, processes which occur due to the fast activation of voltage dependent sodium 
channels. Genome-wide association studies have been performed to examine 
genes, such as SCN10A and SCN5A, which are responsible for the expression of 
voltage-gated sodium channels within cardiac tissue298-300. They have identified a 
number of single-nucleotide polymorphisms which can affect the length of the QRS 
complex. Genetic factors therefore appear to influence QRS duration and could 
explain the differences seen in this study. However, further research exploring the 
relationship between the South Asian genome and electrocardiographic parameters 
is required to clarify this. 
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4.5.3 Atrial ERP and P wave duration 
No difference in atrial ERP or P wave duration was observed between the study 
cohorts. This would suggest that atrial refractoriness and intra-atrial conduction time 
are similar amongst the two ethnicities and that the lower prevalence of AF in South 
Asians is unrelated to these factors. However, it must be remembered that atrial 
ERP could only be measured in around half of subjects. It is therefore conceivable 
that there is a difference between the ethnic groups which was not possible to 
demonstrate. 
4.5.4 Burden of arrhythmia in South Asians 
During a study period of 13 years, 0.31% of Caucasians underwent 
electrophysiology studies compared with only 0.09% of South Asians. Potential 
reasons for this include ethnic variations in the use of healthcare resources although 
the evidence for this is mixed. South Asians have been found to have less 
engagement with cancer screening programmes219, 220, antenatal services221 and 
smoking cessation facilities301. However, they have also been shown to be more 
likely to access specialist chest pain clinics302. An alternative theory is that South 
Asians have biological variations which make them less susceptible to arrhythmia. 
Recent evidence suggests that South Asians are less likely to develop 
bradyarrhythmia233 and the same may be true of tachyarrhythmias such as AF. The 
results of this study suggest ethnic differences in cardiac conduction which may 
have a genetic basis. If the mechanisms responsible for the reduced arrhythmia 
burden in South Asians can be fully determined, they may help in the development 
of novel treatment approaches in the future. 
4.5.5 Limitations 
Firstly, this is a retrospective cohort study raising the possibility of selection and 
recall bias. Selection bias was minimised through the recruitment of consecutive 
South Asian patients who met the eligibility criteria and through the selection of 
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Caucasian controls based only on age and gender, prior to any screening of their 
medical records or electrophysiology study. Recall bias was minimised through the 
comprehensive assessment of the subjects’ medical records. Secondly, the data 
was taken from a single centre and so it may not be generalizable to the whole 
South Asian population. However, the Yorkshire Heart Centre covers a large 
geographical area which includes over 260,000 South Asians and so is likely to 
provide a broad overview of the ethnic group.  
4.6 Conclusion 
South Asians have differences in heart rate, QRS duration and AV nodal function 
compared with Caucasians and these effects are independently associated with 
South Asian ethnicity. These differences may reflect variations in autonomic 
function or even genetic variants and may help to explain why South Asians 
seemingly have a lower burden of arrhythmia. 
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Chapter 5. P wave indices, heart rate variability 
and anthropometry in a healthy South Asian 
population 
5.1 Abstract 
Background:   South Asians have a low prevalence of atrial fibrillation (AF) in 
comparison with White Europeans despite a higher burden of hypertension, 
diabetes mellitus and coronary artery disease. The reason for this disparity is 
unclear but may relate to electrophysiological or structural differences within the 
atria or variations in autonomic function. The researcher aimed to assess these 
areas using a range of non-invasive cardiac investigations. 
Methods:   A prospective cohort study was performed on 200 South Asian and 200 
Caucasian healthy volunteers aged 18-40 years. All subjects underwent 
electrocardiography (ECG), echocardiography and anthropometric measurements. 
Eighty subjects in each cohort underwent 24 hour ambulatory ECG and fifty 
subjects in each cohort underwent exercise testing.  
Results:   Compared with White Europeans, South Asians were of a smaller height 
with lower lean body mass and smaller left atrial size. They had reduced P wave 
dispersion and P wave terminal force in lead V1. South Asians had a lower burden 
of supraventricular ectopy. They had a higher mean heart rate and South Asian 
males had lower heart rate variability, suggestive of sympathetic predominance. 
Exercise capacity was lower in South Asians. 
Conclusions:   South Asians have differences in left atrial size, P wave indices, 
burden of supraventricular ectopy, heart rate, heart rate variability and 
anthropometric measurements. These differences may relate to variations in atrial 
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morphology, atrial electrophysiology and autonomic function and might help to 
explain why South Asians are less susceptible to developing AF. 
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5.2 Introduction 
The prevalence of AF in South Asians is significantly lower than Caucasians despite 
higher rates of conventional risk factors. It is feasible that South Asian ethnicity is 
associated with certain physiological variations with confer protection against the 
development of AF and that these differences are present in South Asians from 
birth.  
The development of AF not only requires an ectopic focus to act as a trigger for the 
arrhythmia but also changes in atrial conduction, increases in atrial size and 
variations in autonomic function to provide an environment capable of maintaining 
it37, 44. Non-invasive cardiac investigations can indirectly assess many of these 
factors without the inherent risks of invasive testing. A 12-lead electrocardiogram 
(ECG) can measure P-wave indices, markers of atrial conduction; an ambulatory 
ECG can determine the burden of supraventricular ectopy (SVE) and measure heart 
rate variability (HRV), a marker of autonomic tone; echocardiography can be used 
to measure atrial size; and exercise testing can assess heart rate recovery, a 
marker of vagal activity, and exercise capacity. 
West Yorkshire, England, has a population of over two million,11.9% of whom are of 
South Asian descent267. It is therefore an ideal setting to study why South Asians 
have less AF. The researcher hypothesized that South Asians would have 
differences in atrial electrophysiology and autonomic function compared with White 
Europeans and aimed to assess this by performing a range of non-invasive cardiac 
investigations. Healthy volunteers were studied to determine the effects of ethnicity 
on these measurements without potential bias from co-existent cardiovascular 
conditions. 
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5.3 Methods 
5.3.1 Study population 
A single centre prospective cohort study on healthy South Asian and Caucasian 
volunteers aged 18 to 40 years was performed between 14th February 2017 and 14th 
December 2017. Subjects were recruited from Leeds Teaching Hospitals NHS 
Trust, the University of Leeds and local community centres using poster and email 
advertisements (Figure 16). The study was further publicised at stalls during the 
University of Leeds Fresher’s week and the annual Leeds Sikh festival, and through 
attendances at local Mosques, Mandirs, Gurdwaras and South Asian sports centres. 
 
Figure 16. Examples of poster advertisements 
 
Subjects were excluded if there was a history of cardiovascular disease, 
hypertension, diabetes mellitus or dyslipidaemia or if they had evidence of structural 
heart disease on initial 
Figure 17. Example of social media advertisement 
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screening. Adults over the age 
of 40 were not recruited in 
order to minimise the risk of 
subjects having undiagnosed 
cardiovascular disease.  
Ethnicity was self-reported and 
fell into two categories: South 
Asian (defined as Indian, 
Pakistani, Bangladeshi, Sri 
Lankan or Nepalese) and 
Caucasian (defined as White 
British or White European). All 
subjects lived in West 
Yorkshire and all were born in 
the United Kingdom except for 
four South Asians who were 
born in the Indian sub-continent 
and two White Europeans who 
were born in Europe. 
After obtaining informed consent, all subjects underwent anthropometric and blood 
pressure measurements, transthoracic echocardiography and 12-lead ECG. Based 
on the researcher’s power calculations, a cohort of 160 volunteers underwent a 24-
hour ambulatory ECG and 100 volunteers underwent exercise testing.  
The study was approved by the London - Surrey Borders Ethics Committee (REC 
reference 16/LO/2220). 
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5.3.2 Anthropometric measurements 
All measurements were performed by a single investigator in order to reduce 
variability. Height was measured to the nearest millimetre using a stadiometer 
(SECA, model 799, Hamburg, Germany). Participants were asked to remove their 
shoes and stand with 
their feet together, heels 
against the back-board, 
knees straight and 
looking straight ahead 
(with their eyes at the 
same level as their ears). 
They were then asked to 
fully inhale and stand tall 
and whilst in this position, 
the measuring arm was 
moved down on to their 
head and the 
measurement 
recorded303. Weight was 
measured to the nearest 100 grams using a digital scale (SECA, model 799, 
Hamburg, Germany). Participants were asked to remove their shoes and wear light 
clothing. They were asked to stand still with one foot on each side of the scale, 
facing forward with their arms by their sides. Once the measurement was stable, it 
was recorded303. Body mass index (BMI) was calculated by dividing weight by the 
square of the height and body surface area (BSA) was calculated using the 
Mosteller method (see Section 3.3.3)274. 
Figure 18. Height and weight measurement using a 
stadiometer 
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Waist and hip circumference were calculated to the nearest centimetre with an 
anthropometric tape (Gulick II tape measure, Country Technology, Wisconsin, 
USA). Measurements were taken without clothing or over very light clothing if this 
was not possible. For waist circumference, measurements were taken at the 
midpoint between the lower margin of the last palpable rib and the top of the iliac 
crest with the participants arms relaxed at their sides and their feet together and at 
the end of a normal expiration303. For hip circumference, measurements were taken 
at the maximal circumference over the buttocks with the participants arms relaxed at 
their sides and their feet together303. 
 
Figure 19. Waist and hip circumference measurement 
 
Body fat content was assessed using the skinfold thickness technique304. 
Participants were asked to stand in an upright position and all measurements were 
taken on the left-side of the body using a Harpenden skinfold caliper (HSK-BI, 
Burgess Hill, United Kingdom) to the nearest 0.1mm. Measurements were taken at  
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Figure 20. Skinfold thickness measurements 
A. Bicep       B. Tricep       C. Subscapular       D. Suprailiac 
  
A. B. 
C. D. 
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the following sites: tricep (halfway between the acromion process and the olecranon 
process), bicep (at the same level as the tricep skinfold), subscapular (20mm below 
the lower angle of the scapula, at an angle of 45° to the horizontal) and suprailiac 
(20mm above the iliac crest in the mid-axillary line at 45° to the horizontal).  At each 
site, the skinfold was firmly grasped by the investigator’s thumb and index finger 
and pulled away from the body. The caliper was placed onto the skinfold and the 
measurement was taken four seconds from release of the caliper. Skinfolds were 
measured in triplicate and the mean of the three values was used in analysis. 
Skinfold measurements were converted into body fat using the Durnin-Womersley 
method305: 
 
Table 17. Durnin-Womersley method305 
Age 
(years) 
Body density 
(male) 
Body density 
(female) 
Body fat 
(%) 
18-19 1.1533 - (0.0630*L) 1.1549 - (0.0678*L) 
(495/Body Density) - 450 
20-29 1.1631 - (0.0632*L) 1.1599 - (0.0717*L) 
30-39 1.1422 - (0.0544*L) 1.1423 - (0.0632*L) 
40 1.1620 - (0.0700*L) 1.1333 - (0.0612*L) 
Abbreviations: L, log of the sum of skinfolds 
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5.3.3 Blood pressure measurement 
Blood pressure was measured in 
duplicate after subjects had rested for 10 
minutes using a semiautomatic validated 
device (model HEM-59, Omron 
Healthcare, Netherlands). Measurements 
were taken using an appropriate sized 
cuff on the right arm with the subject in a 
seated position. 
 
5.3.4 Transthoracic 
echocardiogram 
A focussed transthoracic echocardiogram (Vivid S6 and Vscan, GE Healthcare, 
Milwaukee, USA) was performed on all volunteers to screen for evidence of 
significant (moderate or severe) valvular heart disease or left ventricular 
dysfunction. Left atrial diameter was measured in the parasternal long-axis view at 
ventricular end-systole.     
Figure 22. Left atrial diameter measured by transthoracic echocardiography 
Figure 21. Blood pressure measurement 
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5.3.5 Electrocardiogram 
Standard 12-lead ECGs were acquired digitally (Norav PC-ECG 1200, Norav 
Medical Ltd, Israel) at a calibration of 10mm/mV and a speed of 25mm/s. ECG data 
was analysed digitally (Resting PC-ECG Application version 5.514, Norav Medical 
Ltd, Israel) by a single operator who was blinded to the study population. Four 
electrodes were attached to the arms and legs, slightly proximal to the wrist/ankle. 
Six electrodes (V1-V6) were placed across the precordium in the conventional 
anatomical positions as demonstrated in figure 23. 
 
Figure 23. Standard precordial electrode placement 
 
Heart rate, baseline ECG intervals and P wave indices which have been shown to 
be associated with the development of AF242, 245, 250, 256 were recorded.  Maximum, 
minimum and mean P wave duration (the onset and offset points of the P wave 
were defined as the intersection point of upward or downward deflection in relation 
to the isoelectric line) and P wave amplitude were measured in all 12 leads. P wave 
dispersion (derived from the difference between maximum and minimum P wave 
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duration) and P wave terminal force in lead V1 (PWTF-V1, defined as the product of 
the duration and amplitude of the negative terminal portion of the P wave) were also 
calculated. Measurements were made manually using electronic calipers at a 
calibration of 40mm/mV and a sweep speed of 200mm/s. 
5.3.6 24 hour electrocardiogram 
Ambulatory ECG monitoring was performed over a 24 hour period using a 3-lead 
Holter monitoring device (Lifecard CF Holter, Spacelabs Healthcare, USA). 
Electrodes were attached under the right and left clavicles in the mid-clavicular line 
and on the lower edge of the left rib cage. 
 
Figure 24. Ambulatory 3-lead ECG placement 
 
Subjects were encouraged to continue their usual daily activities, including exercise. 
Recordings were digitally sampled and analysed (Pathfinder SL, Spacelabs 
Healthcare, USA) by two operators who were blinded to the study population. The 
burden of SVE or arrhythmia was recorded. HRV was measured after the manual 
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removal of artefact and ectopy. Ambulatory ECGs with less than 18 hours of 
recording or with less than 90% of the recording suitable for analysis were excluded 
to avoid confounding effects of circadian variations in HRV. 
Time-domain and frequency-domain measures of HRV were analysed according to 
previously published guidelines (see section 1.5.4.3)263. Time-domain 
measurements included the standard deviation of all normal RR intervals (SDNN), 
the standard deviation of the average normal RR intervals in all 5 minute segments 
of the entire recording (SDANN), the mean of the standard deviations of all normal 
RR intervals for each 5 minute segment of the entire recording (SDNN index), the 
square root of the mean of the sum of the squares of differences between adjacent 
normal RR intervals (rMSSD) and the integral of the total number of all normal RR 
intervals divided by the height of the histogram of normal RR intervals (HRV 
triangular index). Spectral analysis was performed using the fast Fourier transform 
method. Three frequency bands were calculated: very low frequency power (VLF, 
0.017-0.049 Hz), low frequency power (LF, 0.05-0.15 Hz) and high frequency power 
(HF, 0.15-0.35 Hz). 
5.3.7 Exercise test 
Treadmill stress testing was performed according to the standard Bruce protocol306. 
A 12-lead ECG was attached with precordial electrodes placed in the standard 
positions (Figure 23). Limb leads were attached to the right and left infraclavicular 
fossae (medial to the border of the deltoid muscle) and iliac fossae rather than the 
arms and legs in order to minimise excessive movement in the limb wires (Mason-
Likar 12-lead position307). A resting ECG and blood pressure were performed prior 
to the test commencing at 1.7 miles-per-hour at a 10% gradient. The speed and 
gradient were then increased every 3-minutes (Table 18) until the subject reached 
maximal workload and requested termination of the test. At this point, subjects 
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entered an active recovery phase with the treadmill at a speed of 1.5 miles/hour and 
a gradient of 2% before a passive recovery phase of four minutes with subjects 
resting in a semi-recumbent position. Heart rate recovery, defined as the difference 
in heart rate between peak exercise and after one minute of active recovery was 
recorded. 
Table 18. Standard Bruce protocol stages 
Stage Time (minutes) 
Speed 
(miles/hour) 
Gradient 
(%) 
1 3 1.7 10 
2 6 2.5 12 
3 9 3.4 14 
4 12 4.2 16 
5 15 5.0 18 
6 18 5.5 20 
7 21 6.0 22 
 
5.3.8 Statistical analysis 
The researcher’s power calculations were based upon the results of previous 
studies which had demonstrated a standard deviation (SD) of 12ms for P wave 
duration, 8ms for P wave dispersion, 33mV for P wave amplitude, 1.8mm•s for 
PWTF-V1, 0.5ms for SDNN and 9 beats-per-minute for heart rate recovery50, 308, 309. 
The researcher calculated that a sample size of 400 subjects would have 80% 
power to detect a difference of 5ms for P wave duration, 2ms for P wave dispersion, 
11mV for P wave amplitude and 0.6mm•s for PWTF-V1 at a 5% significance level. 
The researcher calculated that a cohort of 160 subjects for ambulatory ECGs and 
100 subjects for exercise tests would have 80%power to detect a difference of 
0.1ms for SDNN and 6 beats-per-minute for heart rate recovery at a 5% significance 
level. 
Statistical analysis was performed using SPSS (IBM SPSS Statistics Version 22.0, 
IBM Corporation, Armonk, New York). Normality of data was tested using a Shapiro-
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Wilk test. Continuous variables were expressed as mean ± SD if normally 
distributed or median (interquartile range [IQR]) if non-normally distributed. Student t 
test or Mann Whitney U test were used to compare continuous variables depending 
on normality. Categorical variables were expressed as percentages and compared 
using Pearson’s chi-square test. P values of less than 0.05 were considered 
statistically significant. 
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5.4 Results 
5.4.1 Study cohort 
A total of 200 South Asians and 200 White Europeans were recruited. All subjects 
underwent ECG, echocardiography and anthropometric measurements. Eighty 
individuals from each cohort underwent 24 hour ambulatory ECG and fifty 
individuals from each group underwent exercise testing (table 19). 
5.4.2 Anthropometric measurements 
South Asians were of a significantly smaller height, lower body weight, reduced BSA 
and lower lean body mass in comparison with White Europeans (table 19). 
Waist:hip ratio was higher in South Asians but there was no difference in BMI. 
Importantly, South Asians had evidence of a smaller left atrium, even after 
correction for BSA. 
5.4.3 12-lead ECG and P wave indices 
South Asians had a narrower QRS complex in comparison to White Europeans and 
South Asian females also had a shorter QTc interval (table 20). There was no 
difference in the PR interval or cardiac axis. 
P wave dispersion and PWTF-V1 were significantly lower in South Asians compared 
with White Europeans. South Asian females had increased P wave duration but no 
difference was seen in South Asian males. P wave amplitude was similar in both 
ethnic groups. 
5.4.4 24 hour ECG and heart rate variability 
South Asians had higher average heart rates and a significantly smaller burden of 
SVE (table 21). South Asian males had reduced HRV in all time-domain measures 
and LF with a trend towards a lower VLF and HF (table 21). No differences in HRV 
were seen in females.  
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Data from six South Asian females was invalid due to either artefact or prolonged 
removal of the ECG leads. 
5.4.5 Exercise test 
Total exercise time was lower in South Asians and they achieved a lower maximum 
metabolic equivalents (METs, table 22). There was no difference in heart rate 
recovery at one minute. 
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Table 19.  Baseline characteristics 
 Male Female 
 
Caucasian South Asian p-value Caucasian 
South 
Asian p-value 
Subjects 100 100 * 100 100 * 
Age, years 28.0 (7) 28.0 (13) 0.757 23.5 (8) 22.0 (8) 0.687 
Alcohol 
consumption, 
units/week 
10.0 (16) 0.0 (2) <0.001 5.0 (10) 0.0 (0) <0.001 
BP- systolic, 
mmHg 
128.3±11.8 129.0±11.
6 
0.674 122.4±10.0 120.5±12.
3 
0.313 
BP- diastolic, 
mmHg 
77.7±8.5 78.1±9.8 0.781 78.8±8.8 79.2±9.7 0.720 
Height, cm 180.5±6.3 173.8±6.8 <0.001 165.6±6.2 161.3±5.8 <0.001 
Weight, kg 81.3 (19.4) 75.0 (16.8) <0.001 62.6 (11.8) 59.5 (13.7) 0.047 
Body mass index, 
kg/m2 
24.6 (4.6) 24.2 (4.4) 0.226 22.9 (4.5) 22.9 (4.7) 0.546 
Body surface 
area, m2 
2.0 (0.3) 1.9 (0.3) <0.001 1.7 (0.2) 1.6 (0.2) 0.006 
Waist 
circumference, 
cm 
82.0 (17) 83.0 (13) 0.658 71.0 (11) 74.0 (16) 0.059 
Hip 
circumference, 
cm 
99.0 (12) 96.0 (10) <0.001 95.0 (10) 94.0 (12) 0.769 
Waist:hip ratio 0.83 (0.1) 0.85 (0.1) 0.023 0.75 (0.1) 0.79 (0.1) <0.001 
Biceps SFT, mm 5.4 (3.3) 5.6 (4.1) 0.784 8.2 (4.1) 9.2 (4.8) 0.048 
Triceps SFT, mm 11.9 (6.7) 10.6 (7.7) 0.282 18.7 (7.7) 17.7 (8.5) 0.476 
Subscapular SFT, 
mm 
13.1 (8.4) 15.9 (8.5) 0.003 14.1 (6.6) 18.8 (8.8) <0.001 
Suprailiac SFT, 
mm 
23.6 (13.8) 27.0 (14.6) 0.027 20.1 (11.0) 26.3 (9.6) <0.001 
Body fat, % 21.9±5.4 22.6±5.4 0.356 29.2±4.7 31.4±5.0 0.001 
Fat mass, kg 17.5 (8.9) 16.4 (7.9) 0.301 17.6 (6.3) 18.1 (8.2) 0.538 
Lean body mass, 
kg 
63.4 (12.1) 57.8 (10.2) <0.001 45.4 (7.0) 41.5 (7.3) <0.001 
LA diameter, cm 3.3 (0.6) 3.0 (0.4) <0.001 2.8 (0.4) 2.6 (0.5) 0.001 
LA diameter/BSA, 
cm/m2 
1.64 (0.1) 1.58 (0.1) <0.001 1.64 (0.0) 1.58 (0.1) 0.008 
Values displayed are mean ± SD or median (interquartile range). 
Abbreviations: BP, blood pressure; SFT, skinfold thickness; LA, left atrial, BSA, body surface area. 
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Table 20.  Reference ranges for South Asian and Caucasian ECG and P-wave 
indices 
 Male Female 
 
Caucasian South Asian 
p-
value Caucasian 
South 
Asian 
p-
value 
Heart rate, 
beats/minute 
63.0 (16) 67.0 (17) 0.004 72.0 (17) 72.0 (15) 0.960 
PR, ms 154.0 (28) 150.0 (29) 0.134 144.0 (22) 144.0 (32) 0.889 
QRS, ms 84.0 (10) 78.0 (6) <0.001 76.0  (8) 74.0 (6) 0.002 
QTc, ms 387.0 (30) 382.0 (24) 0.173 400.0 (29) 395.0 (27) 0.038 
P axis 44.5 (35) 46.5 (25) 0.886 41.5 (32) 44.0 (26) 0.347 
QRS axis 48.0 (38) 49.0 (35) 0.845 51.0 (34) 49.0 (30) 0.545 
T axis 29.5 (25) 28.0 (24) 0.572 30.0 (23) 28.0 (28) 0.691 
Maximum P 
wave duration, 
ms 
110.0 (12) 110.0 (12) 0.453 102.0 (12) 106.0 (12) 0.002 
Minimum P 
wave duration, 
ms 
82.0 (10) 84.0 (10) 0.073 76.0 (12) 84.0 (8) <0.001 
Mean P wave 
duration, ms 
99.0 (8) 99.0 (9) 0.251 91.0 (10) 95.0 (7) <0.001 
P wave 
dispersion, ms 
28.0 (12) 25.0 (12) 0.039 24.0 (12) 22.0 (12) 0.004 
Maximum P 
wave 
amplitude, mV 
0.12 (0.06) 0.12 (0.04) 0.883 0.12 (0.04) 0.12 
(0.04) 
0.783 
Minimum P 
wave 
amplitude, mV 
0.03 (0.01) 0.03 (0.02) 0.937 0.04 (0.02) 0.04 
(0.01) 
0.618 
Mean P wave 
amplitude, mV 
0.07 (0.02) 0.07 (0.02) 0.617 0.07 (0.03) 0.07 
(0.02) 
0.742 
P wave 
amplitude- 
lead II, mV 
0.11 (0.05) 0.11 (0.05) 0.407 0.11 (0.05) 0.11 
(0.05) 
0.998 
P wave 
amplitude- 
lead V1, mV 
0.08 (0.04) 0.07 (0.03) 0.370 0.07 (0.04) 0.07 
(0.03) 
0.883 
P wave 
terminal force, 
mm•s 
0.031 (0.04) 0.021 
(0.03) 
0.023 0.036 (0.04) 0.024 
(0.04) 
0.030 
Values displayed are median (interquartile range). 
Abbreviation: mm•s, product of millimetres and seconds. 
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Table 21.  24 hour electrocardiogram and heart rate variability data 
 Male Female 
 
Caucasian South Asian p-value Caucasian 
South 
Asian p-value 
Subjects 40 40 * 40 34 * 
Age, years 30.0 (6) 32.0 (11) 0.388 24.5 (11) 24.0 (9) 0.815 
Length of 
recording, minutes 
1332.8±88.5 1327.9±91.6 0.844 1350.7±78.
9 
1292.1±84.
5 
0.015 
Heart rate 
(minimum) 
49.0±6.1 53.8±6.7 0.001 53.6±7.7 56.2±4.8 0.048 
Heart rate 
(maximum) 
140.1±22.0 137.6±18.0 0.966 146.2±18.2 148.7±18.0 0.517 
Heart rate 
(mean) 
72.6±7.6 78.4±7.4 0.001 75.8±8.5 81.2±7.4 0.003 
SVE total % of 
recording 
0.0041 
(0.004) 
0.0015 
(0.002) 
0.024 0.0020 
(0.004) 
0.0000 
(0.001) 
0.008 
HRV: Time- 
domain measures 
      
SDNN, ms 170.1 (59.6) 155.6 (36.6) 0.011 158.5 (61.4) 150.8 (44.3) 0.206 
SDANN, ms 161.0 (54.9) 140.1 (46.2) 0.036 144.9 (47.6) 128.7 (36.4) 0.155 
SDNN index, ms 68.8 (19.6) 57.0 (17.6) 0.002 63.5 (24.9) 57.8 (12.0) 0.326 
RMSSD, ms 49.9 (26.3) 40.1 (16.8) 0.013 45.9 (29.9) 42.4 (20.9) 0.622 
Triangular index 48.4 (18.2) 42.3 (11.0) 0.010 44.1 (23.4) 43.9 (12.2) 0.416 
HRV: Frequency-
domain measures       
VLF, ms2 1485 (684) 1184 (948) 0.065 1127 (869) 1048 (635) 0.812 
LF, ms2 2004 (1212) 1274 (1423) 0.005 1341 (1091) 1285 (739) 0.803 
HF, ms2 873 (1189) 780 (591) 0.079 941 (1189) 870 (1061) 0.610 
LF/HF, % 3.4 (2.7) 3.1 (2.2) 0.909 2.5 (1.7) 2.3 (1.5) 0.789 
Values displayed are mean ± SD or median (interquartile range). 
Abbreviation: SVE, supraventricular ectopic; HRV, heart rate variability. 
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Table 22.  Exercise test results 
 Male Female 
 
Caucasian South Asian p-value Caucasian South Asian p-value 
Subjects 25 25 * 25 25 * 
Age, years 29.5±6.1 32.7±6.1 0.059 26.2±6.9 25.9±6.0 0.804 
Resting heart 
rate, bpm 
83.3±10.8 85.7±12.8 0.457 90.6±7.8 91.6±10.8 0.711 
Resting systolic 
BP, mmHg 
119.9±7.0 119.2±13.5 0.840 112.8±11.0 104.5±10.0 0.005 
Resting diastolic 
BP, mmHg 
71.5±6.2 77.4±8.2 0.001 72.2±10.3 66.1±8.0 0.038 
Total exercise 
time, seconds 
961.0±180.7 803.2±167.5 0.002 772.0±147.1 633.0±115.6 <0.001 
Maximum heart 
rate, bpm 
191.2±11.0 193.3±10.8 0.473 193.7±9.7 190.0±14.3 0.280 
Maximum 
systolic BP, 
mmHg 
159.2±14.6 157.8±15.0 0.722 137.7±13.9 138.3±16.1 0.883 
Maximum 
diastolic BP, 
mmHg 
70.0±7.6 70.7±6.7 0.794 69.9±8.9 70.5±16.4 0.209 
% of target 
heart rate 
100.0±5.3 103.3±5.1 0.025 100.1±4.6 97.7±6.5 0.140 
Maximum 
METS achieved 
18.7±3.3 15.7±3.1 0.001 15.2±2.9 12.5±2.1 <0.001 
Heart rate at 1 
minute 
recovery, bpm 
160.7±13.4 166.2±12.1 0.122 163.3±11.1 160.7±19.3 0.565 
Heart rate at 6 
minutes 
recovery, bpm 
108.3±12.4 117.6±9.9 0.004 108.3±9.5 111.0±16.8 0.479 
Heart rate 
recovery- 
1 minute, bpm 
30.0±7.4 26.9±6.9 0.139 29.5±7.5 29.2±9.9 0.626 
Values displayed are mean ± SD. 
Abbreviations: bpm, beats per minute; BP, blood pressure; METS, metabolic equivalents. 
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5.5 Discussion 
This study provides normal reference ranges for ECG intervals and HRV in a young 
South Asian population without evidence of cardiovascular disease or its risk 
factors. Additionally, it demonstrates differences in anthropometric measurements, 
P wave indices and HRV between South Asians and White Europeans. 
5.5.1 Baseline characteristics and anthropometric 
measurements 
Height, weight and BSA were all lower in South Asians, consistent with previous 
small observational studies206, 225. Body size correlates with heart chamber 
dimensions and increasing height is closely related to increasing left atrial 
volume102. It is not surprising therefore that South Asians had a smaller left atrium 
compared with White Europeans although interestingly, left atrial size remained 
significantly smaller even after matching for BSA, suggesting that South Asians 
have proportionally smaller atria. Atrial enlargement is associated with a higher risk 
of AF40 due to its effects on atrial refractory periods and the development of re-
entrant circuits294. One study has also found that the impact of height on the risk of 
AF is independent of atrial size and it has been suggested that since increasing 
body size is related to increased stroke volume and cardiac output310, the increased 
risk of AF could be linked to a higher volume load. Consequently, the reduced 
prevalence of AF seen in South Asians could relate to their smaller stature and 
reduced left atrial size. 
My findings show that South Asians have a significantly lower lean body mass, a 
measure which has recently been shown to be the predominant anthropometric risk 
factor associated with the occurrence of AF100. It has been speculated that high lean 
body mass increases stroke volume and cardiac output101 which in turn can lead to 
the development of left ventricular hypertrophy101 and atrial enlargement101. These 
structural changes provide favourable substrate for AF development. Whether lower 
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lean body mass influences the risk of developing AF in South Asians remains to be 
determined.  
Alcohol consumption was significantly lower in South Asians. Alcohol intake is 
closely associated with the development of AF, even when consumed at moderate 
levels109 and this is believed to be due to its effects on atrial conduction, 
morphological alteration and autonomic impairment. Therefore, the lower level of 
alcohol consumption in South Asians may be protective against the development of 
AF. 
5.5.2 P wave indices 
South Asians have significantly lower P wave dispersion and PWTF-V1 in 
comparison to White Europeans. P wave dispersion is a marker of inhomogeneity in 
the propagation of sinus impulses across the atria and is influenced by increases in 
atrial pressure, atrial size and metabolic stress. It has been shown to predict 
paroxysmal lone AF242 as well as AF recurrence248. PWTF-V1 correlates with left 
heart filling pressures, is a specific indicator of left atrial enlargement and is 
associated with an increased risk of AF256. Reduced P wave dispersion and PWTF-
V1 is consistent with South Asians having smaller atrial size. Variations in these 
indices may also reflect differences in the atrial conduction homogeneity and left 
heart filling pressures, both of which would influence AF risk, although more 
invasive techniques are required to confirm this. 
South Asian females unexpectedly had a longer P wave duration compared with 
Caucasian females, implying differences in atrial conduction time. Studies have 
shown that both a prolonged245 and shortened245 P wave duration are associated 
with the development of AF. Therefore, the relevance of this finding in relation to the 
risk of AF in South Asians is uncertain. 
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5.5.3 24 hour ECG and heart rate variability 
South Asians had a lower SVE burden in comparison with White Europeans 
although as one might expect in healthy cohorts, the overall burden of SVE was low 
in both groups. SVE detected on ambulatory monitoring has been shown to 
independently predict AF311.  
South Asians had a significantly higher minimum and mean heart rate compared 
with White Europeans. Heart rate is heavily influenced by the autonomic nervous 
system and a lower heart rate relates to a relative predominance of parasympathetic 
activity which in turn has been linked with a higher AF risk312, 313. 
HRV was within normal range in all subjects. Interestingly, South Asian males had 
significantly lower SDNN, SDANN and triangular index in comparison with 
Caucasian males. These indices are all markers of overall HRV and mainly reflect 
increased sympathetic activity314. They also had lower RMSSD and a trend towards 
lower VLF and HF, all of which are markers of lower parasympathetic activity. 
Differences in HRV have previously been seen in South Asian children315 but to the 
researcher’s knowledge, this is the first time a difference has been demonstrated 
amongst South Asian adult males.  
Overall, the differences seen in heart rate and HRV may reflect differences in 
autonomic function and would be most consistent with South Asians having 
sympathetic predominance. Whether this influences South Asians risk of developing 
AF is less clear.  
5.5.4 Exercise test 
Total exercise time and METs achieved were significantly lower in South Asians 
implying that they are generally less physically active than White Europeans. There 
was a trend towards lower heart rate recovery in South Asian males, suggestive of 
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higher sympathetic tone, but no difference was seen in females. The association 
between exercise and the risk of AF follows a J-shaped curve with increasing 
physical activity modestly reducing the risk of AF but extreme exercise, such as that 
performed by endurance athletes, increasing the risk of AF significantly. There are 
several different mechanisms to explain this. Exercise generally has a positive 
influence on risk factors such as hypertension, diabetes mellitus and obesity and 
has been shown to slow the age-related decline in arterial elasticity and associated 
cardiovascular disease. However, at high levels, exercise can lead to morphological 
changes such as left atrial enlargement and LVH and increases in vagal tone, all of 
which favour AF. Although lower exercise levels are likely to increase the risk of AF 
in South Asians, it is feasible that reduced activity might have the effect of 
minimising structural and autonomic changes within the heart. 
5.5.5 Limitations 
Firstly, this study’s findings are derived from non-invasive investigations and are 
consequently indirect measurements of atrial conduction and autonomic function. 
Nevertheless, this study has identified significant differences between South Asians 
and White Europeans and the findings have highlighted areas of research for future 
clinical, genetic and experimental studies. Secondly, the reported reference ranges 
relate to healthy individuals aged 18 to 40 years of age and so may not be 
applicable to older subjects. Thirdly, these results are taken from a single-centre 
cohort and this may limit the generalisability of the findings.  
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5.6 Conclusion 
In comparison with White Europeans, South Asians are of a smaller stature with 
reduced lean body mass and smaller left atrial size. They have reduced P wave 
dispersion, indicative of less inhomogeneity of atrial conduction, and lower PWTF-
V1, implying smaller atrial size and potentially lower left heart filling pressures. They 
also have a lower burden of SVE. Additionally, South Asians have increased mean 
heart rate and South Asian males have reduced heart rate variability, suggestive of 
sympathetic predominance. These morphological, electrophysiological and 
autonomic variations may help to explain why South Asians have a lower 
prevalence of arrhythmias such as AF. 
 
Figure 25. Summary of findings and their association with risk of atrial fibrillation 
Abbreviations: LA, left atrial; ERP, effective refractory period; LVH, left ventricular hypertrophy; EP, 
electrophysiological; SVE, supraventricular ectopy; AF, atrial fibrillation; PWDi, P wave dispersion; 
APD, action potential duration; PWTF-V1, P wave terminal force in lead V1; HR, heart rate; HRV, heart 
rate variability. 
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Chapter 6. Conclusion 
The overall aim of this body of work was to provide a detailed assessment of the 
morphology and electrophysiology of the South Asian heart and in doing so, 
determine why South Asians have a lower prevalence of AF in comparison to 
Caucasians despite an unfavourable cardiovascular risk profile. 
The disparity in the prevalence of AF amongst South Asians originates from 
observational studies which have relied on standard 12-lead electrocardiogram 
results or primary care records of the arrhythmia. This has led to speculation that 
rather than having lower rates of AF, South Asians were either less likely to engage 
with medical services and therefore not have accurate health records or that they 
were more at risk of paroxysmal AF which would not necessarily be detected with 
short-term cardiac rhythm monitoring. 
Therefore, the initial aim of this work was to clarify AF rates in South Asians with the 
use of more prolonged cardiac rhythm monitoring methods. In a review of South 
Asian and Caucasian pacemaker patients, the researcher found that the cumulative 
incidence of subclinical AF was significantly lower in South Asians with an annual 
event rate of 6.9% compared with 13.9% in Caucasians. It was also shown that the 
lower incidence of subclinical AF was independently associated with South Asian 
ethnicity. 
The South Asian heart appears to have a number of important morphological 
differences in comparison to the Caucasian heart. Firstly, left atrial size is smaller in 
South Asians and the researcher has demonstrated this with the use of 
echocardiography and the reference standard of cardiovascular MRI. Additionally, 
South Asians have reduced left ventricular mass and end-diastolic volume and 
lower stroke volume. These findings would seem logical since the researcher has 
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also shown that South Asians are of a smaller height and lower lean body mass, 
factors which correlate with a lower circulatory volume load and cardiac chamber 
size. Interestingly however, the structural differences seen in the South Asian heart 
remained significant after matching for BSA. This would indicate that the South 
Asian heart is proportionally smaller to the Caucasian heart. Although the exact 
reason for this is uncertain, given that the study population was exposed to similar 
environmental factors, it is likely to reflect genetic variation. 
South Asians seem to have notable differences in terms of atrial electrophysiology.  
In comparison with Caucasians, they have been shown to have a lower burden of 
supraventricular ectopy and differences in P wave indices. P wave dispersion, a 
non-invasive marker of the inhomogeneity of atrial conduction, was lower in South 
Asians and they had reduced PWTF-V1, an indicator of left atrial size and filling 
pressures. 
Additionally, South Asians appear to have differences in autonomic function. Heart 
rate was consistently higher in South Asians, both during invasive and non-invasive 
testing. South Asians had reduced atrioventricular nodal refractoriness during 
electrophysiology studies and South Asian males had lower HRV compared with 
their Caucasian counterparts. A unifying explanation for these findings would be that 
South Asians have sympathetic predominance. 
The morphological, electrophysiological and autonomic differences identified in 
South Asians may help to explain why this ethnic group has a lower prevalence of 
AF. Left atrial size is closely related to the development of AF. As atrial size 
increases, its ability to accommodate and sustain multiple re-entrant circuits also 
increases. Therefore if South Asian atria are smaller, they may be less susceptible 
to re-entry thereby reducing the risk of developing AF. The differences seen in the 
left ventricle are likely to contribute to this effect. Lower left ventricular end-diastolic 
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volume and stroke volume equates to a reduced volume load whilst lower left 
ventricular mass results in reduced left-sided filling pressures. Studies have 
previously shown that left atrial size increases with left heart pressure and volume 
and so if these factors are lower, left atrial enlargement is less likely to develop. 
To facilitate the initiation of AF, a trigger in the form of an ectopic beat is typically 
required. South Asians have been shown to have a lower burden of supraventricular 
ectopy. It would therefore follow that if they have a lower burden of the triggers of 
AF, it is likely that their risk of AF will also be lower. The maintenance of AF requires 
abnormalities within atrial tissue. Inhomogeneity in atrial conduction, usually as a 
consequence of interstitial fibrosis, facilitates the development of re-entrant circuits 
which in turn enable the perpetuation of AF. The researcher has demonstrated that 
a non-invasive marker of this, P wave dispersion, is significantly lower in South 
Asians. This may reflect less heterogeneity in atrial conduction which in turn may 
reduce their chance of developing re-entry, thus lowering their risk of AF.  
The autonomic nervous system plays an important role in the genesis and 
maintenance of AF. The findings, though not conclusive, do imply a difference in 
autonomic function and are most in keeping with increased sympathetic activity. In 
structurally normal hearts, the onset of AF is generally preceded by increased 
parasympathetic activity which produces focal triggers and creates heterogeneity in 
conduction within the atria. If South Asians do have more sympathetic dominance 
with less parasympathetic contribution, this might play a role in reducing their risk of 
developing AF. 
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6.1 Future directions 
Although the findings from this body of work have highlighted differences within the 
South Asian heart, the exact reason for the lower prevalence of AF in this ethnic 
group remains to be fully determined. Further research specifically looking at atrial 
conduction, autonomic function and the genetics of South Asians is therefore 
required. 
With the use of non-invasive techniques, the researcher has provided evidence 
which suggests that South Asians may have less inhomogeneity in atrial 
conduction. It was not possible to directly assess atrial conduction during the 
examination of invasive electrophysiology studies as this is not a part of the 
standard protocol. Intra-atrial conduction can be measured with the use of multisite 
incremental pacing and future work examining this in South Asians would help to 
clarify whether they do have differences in atrial conduction. 
My findings suggest differences in autonomic function in South Asians and support 
the results of previous studies which have implied that South Asians have higher 
sympathetic tone. Due to the complexity of the autonomic nervous system, it 
remains difficult to accurately measure or quantify. More studies examining 
autonomic tone in South Asians are needed in order to provide further evidence and 
help confirm whether this ethnic group does indeed have increased sympathetic 
activity. 
Fundamentally, however, the most exciting area of future research will revolve 
around the genetic profile of South Asians. This population clearly has a lower 
burden of AF and left atrial size, increased heart rate and differences in 
atrioventricular nodal function have all been independently associated with South 
Asian ethnicity. Does this reflect some degree of genetic protection against the 
development of AF? Do South Asians lack common genetic variants which 
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predispose to AF? Alternatively, could the differences in South Asian cardiac 
structure and electrophysiology be related to genetic differences? Genome-wide 
association studies of AF have yet to be performed in South Asians and these will 
be essential if the cause for the lower prevalence of AF in South Asians is to be fully 
determined. 
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